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xviii Table 1.1  Main features of  studies in children relating glucose/insulin outcomes with birth and current size 
Reference  Age  Place  Birth measurements  Childhood measurements  Associations 
Yajnik et aloo  4 years  Pune, India  Birth weight  Weight, height, skinfolds, waist  +ve with current size 
and hip circumference  -ve with birth weight 
Bavdekar et al
43  8 years  Pune, India  Birth weight  Weight, height, skinfolds, waist  +ve with current size 
and hip circumference  -ve with birth weight after 
adjusting for current size 
Whincup et alb I  11  years  England and Wales  Weight, length, ponderal  Weight, height, ponderal index  +ve with current size 
index  -ve with birth weight after 
adjusting for current size 
Crowther et al
62  7 years  South Africa  Birth weight  Height, ponderal index  +ve with PI and skinfolds, -ve 
Skinfolds at 5 years  with current height 
-ve with birth weight after 
adjusting for current size 
Lawlor et al
b3  9 years  Estonia and  Birth weight  BMI, Height  +ve with current size 
Denmark  -ve with birth weight 
Wilkin et aiM  5 years  Plymouth, UK  Birth weight  Weight, BMI, weight change  +ve with current size, no 
since birth  relationship with birth weight 
Sayers sN("  8-14 years  Australia  Birth weight, ponderal  Weight, height  +ve with current size, no 
index  relationship with birth weight 
~  -
8 1.3  Fetal and developmental origins of type 2 diabetes -maternal gestational 
diabetes mellitus (GDM) 
1.3.1 Gestational diabetes- background: Gestational diabetes is defined as "any 
degree of  glucose intolerance with onset or first recognition during pregnancy,,77. 
Recent evidences indicate that fetal over-nutrition as in the case of  maternal GDM, as 
well as growth retardation, is associated with higher prevalence of  adult type 2 DM in 
the offspring. The higher risk in offspring of  diabetic mothers (ODM) underlies the IU' 
shaped association between birth weight and type 2 DM observed in some 
populations71,78.  Among the Pima Indians, the age adjusted prevalence of  the disease 
was increased in both the lowest (30%) and highest (32%) birth weight groups (Figure 
1.1)71. The relationship with high birth weight was lost after adjusting for mothers' 
GDM in this study and in another study from the USA (Figure 1.2)78. Thus, maternal 
GDM could be another important component of  the fetal origins of  adult disease. 
Figure 1.1 Age adjusted prevalence (68% confidence intervals) of diabetes 
according to birth weight among 1179 Pima Indians aged 20-39 years  71 
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10 Figure 1.2 Relative risk ofNlDDM. US Nurses' Study (0=69,526)78 
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Pregnancy itself is a diabetogenic condition. Gestational steroid hormones facilitate the 
supply of  fuels to the fetus by inducing maternal hyperglycaemia
79
• Peripheral insulin 
resistance, a common feature of  normal pregnancy, also enhances fetal nutrition by 
diverting glucose from maternal to fetal tissues, and leads to high circulating levels of 
triglycerides and free fatty acids by way of increased lipolysis during later part of 
pregnancy. GDM results when the f3-cells fail to cope with the increased demand for 
insulin
79
•  GDM increases the risk of  developing type 2 DM later in life, and is 
considered to be a form of  type 2 DM. 
GDM has a strong genetic aetiology, and shares common risk factors with type 2 
DM
77,80. It is common in older, obese women, increased in certain ethnic minority 
groups such as the Pima Indians, and is characterised by high insulin resistance. Similar 
to type 2 DM, adult lifestyle factors like sedentary behaviours and high energy intake 
increase the risk ofGDM. Women's own birth weight has also been shown to be 
associated inversely with the risk of  GDM81. 
Human studies and animal experiments have shown that maternal hyperglycaemia is 
associated with higher neonatal morbidity82,83. The newborns of  diabetic mothers are 
macrosomic and adipose, due to an excess of  'fuels' (glucose, amino acids and fatty 
acids) crossing the placenta,  and concomitant fetal hyperinsulinaemia84,85. 
Hyperinsulinaemia may lead to increased IGF-I receptors and/or the insulin receptor 
may itself have growth-mediating properties85. Macrosomia itself and shoulder dystocia 
may hinder vaginal delivery exposing both the mother and the fetus to operative risks86. 
11 insulin levels of  the adult offspring were normal. However, when challenged with 
glucose infusion, the endocrine pancreas failed to cope with the demand, and they 
became hyperglycaemic. Different mechanisms were related to glucose intolerance in 
these rat offspring depending on severity of  maternal hyperglycaemia. Mild maternal 
diabetes was associated with fetal hyperinsulinaemia, and increased anabolism resulting 
in a deficient ~-cell response in the adult offspring, probably induced by reduced amino 
acid turnover. On the other hand, severe diabetes in the mother resulted in extreme 
hyperglycaemia, disorganised  ~-cell function and perinatal hypoinsulinaemia in the 
offspring. These offspring exhibited peripheral insulin resistance as adults94. 
When female offspring of  experimentally induced diabetic rats became pregnant, they 
developed diabetes, and their offspring (third generation rats) exhibited features of 
offspring of  mildly diabetic rats and developed glucose intolerance when stressed 
during adulthood95. The diabetogenic tendency was thus passed on to subsequent 
generations mimicking genetic inheritance. 
The researchers showed that the above outcomes were present in the third generation rat 
offspring only when their mothers were born to diabetic rats, but not fathers
96
. This 
suggested that the associations shown in these experiments were mediated through 
maternal hyperglycaemia, rather than toxic or mutational effects of STZ. 
Many of  the above findings were replicated in another model, where gestational 
hyperglycaemia was induced by continuous infusion of  glucose in rats during late 
pregnancl
7
. The newborn offspring were hyperinsulinaemic compared to controls and 
had altered glucose tolerance postnatally. Glucose intolerance was more pronounced at 
older ages. There was decreased insulin secretion compared to controls, without a 
significant decrease in pancreatic insulin content, suggesting that impaired insulin 
secretion may be related to decreased ~-cell sensitivity. This model confirmed that the 
long-term effects of maternal diabetes were due to maternal hyperglycaemia rather than 
genes or toxic effects of  STZ as might have argued with the other model. 
The mechanism by which intra-uterine diabetic environment increases the risk of 
obesity/adiposity in the offspring is little studied. The inheritance of genes responsible 
for both obesity and GDM has been implicated by some as a cause
98
. Maternal obesity 
and sedentary behaviours, usually associated with GDM may influence postnatal 
14 Figure 1.5 Mean SD scores for BMI at every age from birth to 21  years, and when 
studied at 26-32 years, for subjects who developed IGT or diabetes- New  Delhi 
Study73.Mean SD  scores are  indicated  by  the  solid  line,  and  95% CI's by  dotted  lines.  The 
mean SD score for the whole cohort is zero. 
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A study similar to Hertfordshire study was carried out in Mysore, south India, in 
1993
121
. The Holdsworth Memorial Hospital (HMH), Mysore has preserved birth 
records for all babies born there since 1934, recording birth weight, length and head 
circumference at delivery. These records were used to trace 518 men and women born 
in the hospital between 1934 and 1954 and still living in Mysore. There was a high 
prevalence of  type 2 DM (15%) in men and women above 40 years, similar to other 
estimations from India. Although, insulin resistance was associated inversely with birth 
weight, the adults with impaired insulin secretion and diabetes were short at birth and 
had a high ponderal index
l21
• This was in contrast to the observations made in Pune and 
among Western populations, where people with low birth weight and low ponderal 
index at birth were at highest risk of  diabetes as adults. There was also a strong 
association in Mysore between higher maternal weight and pelvic diameters, and type 2 
DM. It was suggested that these heavier mothers had gestational glucose intolerance and 
that this could explain their high risk of  diabetes in late middle age
l21
• 
19 Figure 1.6  Prevalence (±SE) of GDM in relation to maternal age and BMI
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The babies born to mothers with GDM were bigger in all measurements, especially 
body fat (skinfold measurements), but also skeletal size (length), and muscle mass 
(MUAC), compared to neonates born to non-diabetic mothers (Figure 1.7). Even in the 
offspring of  non-diabetic mothers, macrosomic changes were seen across the range of 
maternal fasting glucose (Figure 1.8). Irrespective of maternal diabetes, the babies were 
smaller than Western newborns. As in the Pune study, however, they were relatively 
adipose; while all other body measurements were lower than UK babies by>  1 SD, 
subscapular skinfold thickness were relatively spared_ 
Figure 1.7: Standard deviation (SD) scores for mothers with GDM and their babies 
(study population mean = 0)125 
Values are adjusted for gestation, error bars shown are 95% confidence intervals 
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21 1.5.3 Hypotheses: 
•  Children born to mothers with diabetes have more central and total body fat at 5-
years than children born to non-diabetic mothers, and have elevated plasma insulin 
concentrations 
•  Weaker, but significant effects on insulin concentrations and body fat mass and 
distribution will be found in relation to the mother's gestational glucose and insulin 
concentrations, even in offspring of mothers without frank diabetes. 
•  Small size at birth and at one year predicts increased central body fat at 5-years, and 
higher plasma insulin concentrations. 
In the ensuing chapters, I describe the methods adopted and the results obtained in the 
course of  the study. Though not directly related to the above hypotheses, I have also 
included additional chapters on blood pressure and physical activity in children, and 
short and long-term associations of  maternal vitamin D on offspring size and glucose 
and insulin concentrations, as these are relevant to the discussions outlined in the 
current chapter. 
23 2. METHODOLOGY 
Figure 2.1 Mysore, South India 
24 Figure 2.4 New born baby of a study woman 
Figure 2.5 Anthropometric measurement of the neonate 
28 Table 2.2 List of anthropometric measurements carried out at follow-up 
Weight (kg)  Measured using an electronic weighing scale (Seca, Germany), 
naked or in minimal clothing, to the nearest 100g. 
Heightllength (cm)  Measured using Harpenden infant stadiometer during first two 
(crown-heel and crown- years and Microtoise wall-mounted stadiometer thereafter, to the 
buttock/sitting height)  nearest 1 mm. An assistant helped to maintain the child's posture. 
At four years, sitting height was measured using a stool of  known 
height 
Head circumference (cm)  Measured using a fibreglass anthropometric tape to nearest 1 mm 
at the level of  maximum occipito-frontal diameter (farthest point 
of  the occipital protuberance in the back and just above the 
eyebrows in front). 
MUAC (cm)  Measured to the nearest 1 mm, at the mid-point between acromion 
and olecranon processes using a fibreglass anthropometric tape. 
Abdominal circumference  Measured at the level of  umbilicus using fibreglass 
(cm)  anthropometric tape at the end of  expiration. 
Chest circumference (cm)  Measured at the level of  xiphisternum using fibreglass 
anthropometric tape at the end of  expiration. 
Subscapular skinfold  Measured using Harpenden skinfold callipers just below the 
(mm)  inferior angle of  the scapula along the natural direction of  the skin 
cleavage. Readings taken at the end of  5 seconds. 
Triceps skinfold (mm)  Measured at the intersection of  horizontal mid arm line and the 
vertical line at the most posterior point of  the triceps using 
Harpenden callipers. Readings taken at the end of  5 seconds. 
Figure 2.9 Measurement of MUAC  Figure 2.10 Developmental questionnaire 
32 2.5.5 Blood Pressure: Blood pressure was measured on the left arm, using similar 
method as for the children. Measurements were repeated ifBP was high (2150/90), and 
those with persistent high values were referred to a physician. 
2.5.6 Participation Rate: A total of  560 (96%) mothers and 511  (87%) fathers attended 
the clinic; 551 mothers completed the OGTT. Of  the mothers who did not attend, 13 
were post partum women, 9 were pregnant, 3 refused to attend, 2 women had died and 1 
was out of  country. Of  the women who did not complete the OGTT, 2 vomited and did 
not return for a second attempt, 1 refused further samples, 1 was a person with known 
diabetes, and 5 refused. Reasons for non-attendance of  fathers were: 55 refused, 13 were 
out of  country, 6 had died. Of  the fathers who attended, 5 refused blood tests and only 
anthropometric measurements were done for them. 
2.6 Blood processing and assaying 
Blood samples were centrifuged for 15 minutes at 4000 revolutions/minute and stored at 
-80°C after separating the plasma into aliquots (Figure 2.25, Appendix 1). A part of  the 
plasma was used to measure glucose in the hospital laboratory and the results were 
made known immediately to the subjects. If  abnormal, the subjects were referred to a 
hospital consultant and regular follow-ups were done to ensure that the necessary 
consultation was obtained. The rest of  the samples were transported at regular intervals 
on dry ice to the Diabetic Research Centre at the King Edward Memorial Hospital, Pune 
for glucose and insulin assay. 
Figure 2.25 Blood processing 
41 The Pune research centre has a well-established set up for specific insulin assay. It has 
been a part of  the UK quality control system for several years (Registered with UK 
NEQAS quality control scheme). Insulin was assayed a by a time-resolved, 
flouroimmunoassay (DELFIA) method. Antibody was labelled using Europium labelled 
neutralite avidine (Southampton, UK). Intra and inter-assay co-efficients of  variation 
using this method were <5% and <10% respectively. Glucose estimations were repeated 
in Pune, on an Auto analyser (Abbott Laboratories, USA) using a Glucose oxidase-
peroxidase method. 
Glycosylated haemoglobin (HbA1c) was analysed at the diabetes research centre, 
Chennai by Variant HbA1c programme (BIORAD Laboratories, USA) using ion-
exchange liquid chromatography. This centre, established exclusively for 
comprehensive diabetic care was recommended by the leading diabetologists. At the 
time of  the study, the centre used the BIORAD internal quality control assessment, but 
was not a part of  any external quality control scheme. 
2.7 Derived estimates of insulin resistance and secretion. insulin increment 
2.7.1 Homeostasis Model Assessment (HOMA): HOMA, a mathematical model gives 
an estimation of  insulin resistance128. Relative insulin resistance was determined using 
the formula: {fasting insulin (mIU/ml)*fasting glucose (mmol/l)} 122.5. In adults, 
insulin resistance estimated using HOMA correlated well with that from the 
euglycaemic clamp (Rs=0.88), and the hyperglycaemic clamp (R=0.69), the 'gold 
standard' methods. The co-efficients of  variations were, however, high (31 %) 
suggesting low reproducibility128. 
High correlations between insulin sensitivity estimates from HOMA equations and 
euglycaemic clamp estimates (R=0.91) were also seen in children129. However, another 
study showed HOMA as a poor measure of  insulin resistance in children  130. 
Nevertheless, HOMA provides a simple tool to assess insulin resistance in large field 
studies and thus is used widely. 
2.7.2 Insulin increment:Jnsulin increment was derived as a measure of  first phase 
insulin secretion in adults from the formula: (30-minute insulin - fasting insulin)/30-
minute glucose131. Insulin increment estimated by this method was shown to have high 
42 correlations with first phase insulin secretion in an intravenous GTT in adults (r=O.66, 
P<O.OOI). The significance of  this measure in children is not known. 
Glucose and insulin areas under the curve are calculated from a method proposed for the 
adults, the trapezoid rule132. 
43 Figure 3.2a shows that the head circumference of one child was unusually small at 2 
years of  age. The sequence of  head circumference measurement over five years revealed 
considerable shrinkage in size between 1 and 2 years (Figure.3 .2b), which was unlikely. 
The 2-year value was considered spurious and was excluded from the analysis. The total 
number of  values available for anthropometric measurements at each follow-up year, 
and missing values are given in Table 3.1. 
Figure.3.2 Scatter plots of head circumference to test for outliers 
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Table 3.1 Total number of anthropometric measurements available for analysis 
Anthropometry  Birth  i-year  2-year  3-year  4-year  5-year 
N=  663  572  585  600  605  585 
Weight  663  572  585  600  605  585 
Crown-heel length  662*  571'  585  600  605  585 
(CHL)/Height 
Crown-rump length  660*  571'  584¥  599¥  604¥  583¥ 
(CRL)/Sitting height 
Leg length  660*  571'  584¥  599¥  604¥  583¥ 
Head circumference  662*  572  584§  600  605  585 
MUAC  660*  572  585  600  605  585 
Chest circumference  660*  572  585  600  604  585 
Abdomen circumference  660*  572  585  600  605  585 
Triceps skinfold  660*  572  585  600  605  585 
Subscal!ular skinfold  660*  572  585  600  605  585 
Reasons for missing values: *sick baby 11Infant distressed §dropped ¥ measurement missed 
47 Table 3.3 Anthropometric characteristics of  the Mysore children at birth, 1, 2, 3, 4 and 5 years 
Males  Females 
Birth  1  2  3  4  5  Birth  1  2  3  4  5 
NMax=  321  274  282  285  285  280  342  298  303  315  320  305 
Weight (kg)  3.0  8.7  10.8  12.4  14.0  15.4  2.9  8.1  10.3  11.9  13.5  15.0 
(0.4)  (1.1)  (1.2)  (1.4)  (1.6)  (1.9)  (0.4)  (1.1)  (1.3)  (1.4)  (1.7)  (2.0) 
Height/length (cm)  49.5  74.7  84.7  92.1  99.5  106.3  48.7  72.4  83.0  90.7  98.3  105.0 
(2.1)  (2.7)  (3.2)  (3.6)  (4.0)  (4.3)  (2.2)  (2.7)  (3.2)  (3.5)  (34.0)  (4.3) 
Crown -rump length (cm)  32.5  46.2  50.8  54.2  55.9  58.5  32.0  44.9  49.4  53.1  54.9  57.7 
(1.7)  (1.9)  (2.2)  (2.3)  (2.4)  (2.4)  (1.7)  (1.8)  (2.1)  (2.1)  (2.7)  (2.4) 
Leg length (cm)  17.0  27.9  33.9  38.0  43.6  47.7  16.7  27.5  33.6  37.5  43.4  47.3 
(1.4)  (1.5)  (1.8)  (2.2)  (2.3)  (2.5)  (1.6)  (1.6)  (1.8)  (2.1)  (2.6)  (2.4) 
Pond  era  I Index (kg/m3)/BMI (kg/m2)t  24.9  15.9  15.0  14.6  14.1  13.6  25.1  15.4  14.9  14.4  14.0  13.6 
(2.7)  (1.3)  (1.0)  (1.0)  (1.0)  (1.0)  (2.8)  (1.4)  (1.2)  (1.1)  (1.1)  (1.2) 
Head circumference (cm)  34.4  44.7  46.9  48.0  48.8  49.0  33.7  43.6  45.9  46.9  47.8  48.0 
(1.3)  (1.3)  (1.3)  (1.3)  (1.3)  (1.4)  (1.3)  (1.3)  (1.3)  (1.3)  (1.2)  (1.3) 
Mid-arm circumference  (cm)  10.5  14.4  14.8  15.1  15.4  15.4  10.4  13.8  14.5  14.9  15.3  15.4 
(0.9)  (1.1)  (1.0)  (1.0)  (1.1)  (1.2)  (1.0)  (1.1)  (1.1)  (1.1)  (1.2)  (1.3) 
Chest circumference (cm)  32.4  44.6  47.0  48.4  49.8  50.8  32.1  43.2  45.7  46.9  48.3  49.5 
(1.7)  (2.0)  (1.9)  (1.9)  (2.0)  (2.2)  (1.7)  (2.1)  (2.1)  (2.0)  (2.2)  (2.5) 
Abdominal circumference (cm)  30.2  43.4  44.5  46.4  48.1  48.3  30.1  42.4  44.6  46.8  48.4  48.9 
(2.0)  (2.7)  (2.8)  (2.6)  (2.7)  (2.9)  (2.0)  (3.0)  (3.4)  (2.9)  (3.2)  (3.4) 
Triceps skinfold (mm)*  4.1  7.8  7.6  7.5  7.5  7.2  4.2  7.7  7.9  7.9  8.2  8.3 
(3.7,4.8)  (6.8,8.9)  (6.6,8.5)  (6.6,8.7)  (6.8,8.5)  (6.3,8.2)  (3.7,5.0)  (6.8,8.9)  (6.7,9.0)  (6.8,9.2)  (7.0,9.6)  (6.9,9.8) 
Subscapular skinfold (mm)*  4.4  6.4  6.9  6.3  6.0  5.5  4.5  6.4  7.1  7.0  6.7  6.4 
(3.9,5.0)  (5.6,7.4)  (5.8,8.2)  (5.3,7.2)  (5.2,6.7)  (4.8,6.2)  (4.0,5.2)  (5.5,7.4)  (6.0,8.3)  (5.5,7.9)  (5.5,7.9)  (5.1,7.7) 
Means (SD), or *geometric mean (IQR); tPonderal index at birth, BMl at subsequent ages 
50 Table 3.5 Characteristics of the M~sore  children at birth, one and five ~ears and the UK and Dutch reference data. 
MYSORE  UK*  DUTCH 
Birth  BOYS  GIRLS  BOYS  GIRLS  BOYS  GIRLS 
Weight (g)  3.04  2.8,3.3  2.9  2.7,3.2  3.5  3.2,3.8  3.4  3.1,3.7  3.1  2.9,3.3  3.0  2.7,3.3 
Crown-heel length (cm)  49.8  48.6,50.9  48.9  47.7,50.2  49.9  48.7,51.3  49.1  48.2,50.6  50.4  49.2,51.8  49.5  48.1,50.9 
Crown-rump length (cm)  32.6  31.7,33.6  32.0  31.2,33.0  33.8  32.8,34.8  33.0  32.0,34.1 
Leg length (cm)  17.1  16.2,17.8  16.9  16.l,17.6  17.1  16.1,17.7  16.7  15.9,17.4 
Head circumference (cm)  34.7  33.7,35.3  33.8  33.0,34.6  35.5  34.7,36.3  34.8  34.1,35.5  34.8  33.8,35.4  34.0  33.1,34.8 
MUAC (cm)  10.6  10.0,11.2  10.4  9.8,11.0  11.5  10.9,12.1  11.3  10.8,12.0  8.5  7.4,9.4  8.5  7.7,9.l 
Abdominal circumference  32.7  31.5,33.5  32.2  31.2,33.2  33.7  32.5,34.8  33.2  32.1,34.4 
xiphisternum (cm) 
Triceps skinfold (mm)  4.1  3.7,4.8  4.3  3.7,5.0  9.9  8.2,11.9  9.4  7.7,11.16.0 
Subscapular skinfold (mm)  4.5  3.9,5.0  4.5  4.0,5.2  4.5  4.0,5.4  4.7  4.1,5.6  6.0  5.1,7.1  6.0  5.1,7.3 
ONE YEAR 
Weight (g)  8.7  8.0,9.5  8.0  7.4,8.7  10.1  9.4, 10.8  9.5  8.8,10.2  10.1  9.51,10.7  9.4  8.7,9.8 
Crown-heel length (cm)  73.9  72.4,76.0  72.1  70.7, 74.3  75.5  73.8,77.2  73.9  72.3,75.6  77.4  76.1,78.8  75.9  74.0,77.1 
Crown-rump length (cm)  46.2  44.8,47.6  44.7  43.7,46.0  49.2  48.4,50.1  48.0  46.7,49.0 
Leg length (cm)  27.9  26.9,28.8  27.5  26.5,28.4  27.8  26.4,29.1  27.7  26.6,28.9 
Body mass index (kg/m2)  15.8  14.9, 16.8  15.2  14.5,16.2  17.6  16.8,18.6  17.3  16.4,18.2  15.9  15.1,16.7  15.4  14.5,16.2 
Head circumference (cm)  44.8  43.9,45.5  43.5  42.7,44.4  47.7  46.7,48.7  46.5  45.6,47.4  48.1  47.2,48.8  46.6  45.8,47.2 
MUAC(cm)  14.3  13.6,15.1  13.8  13.0, 14.5  15.5  14.7,16.3  15.0  14.l,15.8 
Triceps skinfold (mm)  7.8  6.8,8.9  7.8  6.8,8.9  12.0  10.2, 13.8  11.8  9.9,13.7  9.8  8.1,11.8  9.4  7.8,11.1 
Subscapular skinfold (mm)  6.3  5.6, 7.4  6.3  5.5, 7.4  8.3  6.8, 10.1  8.3  7.1,9.7  6.0  5.0,7.l  6.0  5.1,7.3 
FIVE YEARS 
Weight (g)  15.1  14.2,16.6  14.7  13.6,16.1  18.6  17.2,20.2  18.3  16.8,20.1  20.2  18.7,21.6  18.7  17.4,20.4 
Height (cm)  106.1  103.3,109.1  104.9  102.1,107.6  109.6  106.6,112.6  108.9  105.9,111.9  114.5  111.2,117.5  113.1  110.2,115.7 
Sitting height (cm)  58.5  56.9,60.0  57.6  56.1,59.2  65.2  63.4,66.6  63.9  62.4,65.3 
Leg length (cm)  47.6  45.9,49.3  47.2  45.9,48.6  49.3  47.4,51.1  49.2  47.4,50.7 
Body mass index (kg/m2)  13.5  13.0,14.3  13.4  12.7,14.2  15.5  14.8,16.4  15.5  14.6,16.5 
Head circumference (cm)  49.0  48.0,49.9  48.1  47.1,49.0  52.8  51.7,53.8  51.7  50.9,52.5  52.8  51.8,53.7  51.6  50.6,52.5 
MUAC (cm)  15.3  14.6,16.1  15.2  14.5,16.1  20.3  19.3,21.1  20.0  19.2,20.6 
Triceps skinfold (mm)  7.2  6.3,8.2  8.1  6.9,9.8  8.7  7.3,10.4  10.2  8.5,12.0  8.4  7.1,9.5  9.6  8.2,11.1 
SubscaEular skinfold (mm)  5.3  4.8,6.2  6.0  5.1,7.7  5.4  4.5,6.4  6.1  5.1,7.5  5.1  4.4,6.4  5.6  4.8,6.6 
Median (IQR), *  Southampton babies for birth measurements 
55 3.3.4 Centile curves. This study has produced high-quality anthropometric data from 
birth to five years for children belonging to a wide range of  socio-economic 
backgrounds. I derived centile curves representing the 3
rd
,  10
th
, 25
th
, 50
th  75
th  90
th and 
9ih percentiles for each measurement. Figure 3.6 shows the weight centiles for Mysore, 
and a comparison with the Dutch children (Figure in the inset). Mysore children were 
lighter than Dutch children between 1 and 5 years; at five years, 97% of  the study 
children were below the median Dutch weight. Centile graphs for other measurements 
are included in the appendix (Appendix 4). 
Figure 3.6 Centile curves of  weight for Mysore girls (compared to Dutch girls in the 
inset figure) 
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57 3.4.3 Offspring of diabetic fathers: Forty-one fathers (8.5%) had diabetes at 5-year 
follow-up (17 previously diagnosed and 24 diagnosed from fasting blood samples). Their 
offspring had lower birth weight, and smaller MUAC than control children (Table 3.6, 
Figure 3.8). Except leg length, which was similar, all neonatal measurements were 
significantly smaller than those of  ODM. There were no differences in anthropometric 
measurements between offspring of  diabetic fathers and controls between 1 and 5 years. 
Table 3.6  Characteristics  of offspring of diabetic  mothers,  diabetic  fathers  and 
control children 
ODM  pf  Control  pt  Offspring of 
children  diabetic fathers 
NMax=  41  548  41 
Birth 
Gestational age (weeks)  39.1  (1.2)  0.8  39.0  (1.8)  0.9  39.1  (1.2) 
Weight (g)  3344  (421)  <0.001  2973  (408)  0.05  2869  (305) 
Crown-heel length (cm)  50.5  (2.3)  <0.001  49.2  (2.1)  0.4  48.9  (1.9) 
Ponderal index (kg/m
3
)  26.0  (2.5)  0.01  24.9  (2.7)  0.3  24.5  (1.8) 
MUAC(cm)  11.3  (0.8)  <0.001  10.5  (0.9)  0.03  10.2  (0.7) 
*Triceps skinfold (mm)  5.1  (4.6,6.1)  <0.001  4.2  (3.7,4.9)  0.06  4.0  (3.6,4.4) 
*Subscapular skinfold (mm)  5.3  (4.7,6.2)  <0.001  4.4  (4.0,5.0)  0.053  4.2  (3.8,4.6) 
One year 
Weight (kg)  8.5  (1.2)  0.8  8.4  (Ll)  0.5  8.3  (1.0) 
Crown-heel length (cm)  73.5  (2.5)  0.6  73.3  (2.9)  0.3  72.8  (2.6) 
Body mass index (kg/m
2
)  15.6  (1.7)  0.9  15.7  (1.4)  0.9  15.6  (1.5) 
MUAC (cm)  14.3  (Ll)  0.2  14.1  (Ll)  0.8  14.1  (1.3) 
*Triceps skinfold (mm)  7.8  (6.9,9.5)  0.7  7.7  (6.8,8.9)  0.995  7.8  (6.6,8.8) 
*Subscapular skinfold (mm)  6.5  (5.3,7.9)  0.8  6.4  (5.5,7.3)  0.7  6.4  (5.6,7.1) 
Five years 
Weight (kg)  15.8  (2.1)  0.09  15.2  (2.0)  0.96  15.2  (1.9) 
Crown-heel length (cm)  106.0  (4.5)  0.6  105.6  (4.4)  0.6  106.0  (4.3) 
Body mass index (kg/m
2
)  14.0  (1.2)  0.03  13.6  (Ll)  0.7  13.5  (1.0) 
MUAC (cm)  15.9  (1.3)  0.006  15.3  (1.2)  0.96  15.3  (1.2) 
*Triceps skinfold (mm)  8.5  (6.7,10.3)  0.01  7.7  (6.5,8.9)  0.2  8.0  (7.1,8.9) 
*SubscaEular skinfold (mm)  6.6  (5.2,8.3)  0.01  5.9  (4.9,6.9)  0.4  6.1  (5.1,7.1) 
Means (SD), or *geometric mean (lQR) tp for the difference between offspring of  diabetic mothers and 
controls  tp for the difference between offspring of  diabetic fathers and controls 
59 Figure 3.8 Mean SD scores for anthropometry relative to control offspring 
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3.4.4 ODM- gender difference in skinfold thickness: The sex difference in body fat 
among infants of  diabetic mothers was compared to control children by calculating the 
percentage difference in skinfold thickness between sexes in both groups: % extra 
skinfold thickness in females = (skinfold measurement in girls- skinfold measurement in 
boys/ skinfold measurement in boys)*100. At birth, the sex difference in subscapular 
skinfold measurements was 4% in the ODM, while it was 2% for controls (2.5% and 
1.4% for triceps skinfold). The difference increased over ensuing years. By 5-years of 
age, the subscapular skinfolds of  females were 40% larger than in males (27% for triceps 
skinfold). The corresponding Figures in the control group were 14% and 13% (Figure 
3.9). Interaction term, sex x maternal GDM status was statistically significant for 
subscapular skinfold thickness, P=0.04. 
61 Figure 3.9: Difference in subscapular skinfold thickness between sexes 
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3.5 Relationships to parental glucose and insulin in control children 
.... 
5 
An earlier study has reported a positive association between maternal fasting glucose 
concentrations during pregnancy in the absence of diabetes and offspring size at birth
102
. 
I examined for similar associations between maternal glucose and insulin areas under the 
curve (GAUC and lAUC) and offspring anthropometry in control children. 
3.5.1 Maternal GAVC and IAVC: At birth, none of  the anthropometric measurements 
ofthe offspring born to control mothers was associated with maternal GAUC or lAUC. 
At 5 years, offspring weight, height, BMl, MUAC and head circumference were 
positively associated with maternal GAUC (Table 3.7). However, none of  these 
associations were statistically significant. A statistically significant 'u' shaped 
association was noticed between maternal GAUC and offspring skinfolds with higher 
values observed both in lowest and highest quartiles of  maternal glucose concentrations 
(Table 3.7). These associations remained statistically significant after adjusting for 
maternal skinfolds and socio-economic status of  the family (Table 3.7). 
Relationships with maternal insulin concentrations were much stronger than those with 
GAUC. There was a significant positive association between maternal lAUC and all 
62 Table 3.9 Multiple regression analysis to show the predictors of  anthropometry at five 
years (adjusted for sex) 
Weight  Height  BMI  Head  AMA  Triceps  Subscapular 
(kg)  (cm)  (kg/m2)  circumference  (cm2)  (mm)  (mm) 
{cm} 
Birth size*  /3  1.3  0.62  0.05  0.48  0.36  1.01  1.06 
P  <0.001  <0.001  0.01  <0.001  <0.001  0.4  <0.001 
SES (score)  /3  0.06  0.16  0.02  0.04  0.03  1.004  1.003 
P  0.001  <0.001  0.1  0.003  0.06  0.09  0.2 
MOTHERS 
Height (cm)  /3  0.06  0.18  0.01  0.01  0.01  1.01  1.003 
P  0.001  <0.001  0.3  0.3  0.4  0.02  0.2 
BMI (kg/m2)  /3  0.04  0.05  0.04  -0.03  0.04  1.004  1.002 
P  0.04  0.2  0.004  0.02  0.04  0.2  0.4 
Gestational GAUe  /3  -0.0002  -0.001  0.00  0.00  -0.0002  1.00  -1.00 
(mmol)  P  0.6  0.5  0.97  0.998  0.6  0.99  0.7 
Gestational lAue  /3  0.000  0.00  0.00  0.00  0.00  1.00  1.00 
P  0.02  0.4  0.007  0.02  0.4  0.001  0.02 
FATHERS 
Height (cm)  /3  0.04  0.17  -0.02  0.02  0.02  -1.003  -1.003 
P  0.01  <0.001  0.08  0.05  0.1  0.053  0.2 
BMI (kg/m2)  /3  0.04  0.04  0.03  0.03  0.06  1.003  1.001 
P  0.2  0.4  0.09  0.1  0.02  0.4  0.9 
* Corresponding birth measurement, exponentiated ~ for skinfold measurements. 
3.7 Summan: of main findings 
Anthropometric characteristics of  the Mysore neonates were similar to those described 
for babies from other parts of  India. Smaller size of  the Mysore children at five years 
may be due to different sampling procedures in the two studies. The diverse genetic 
makeup of  populations in different parts of  India and a broad range of  socio-economic 
status in Mysore may be other reasons for these small differences. 
Comparison of  Mysore neonates with white Caucasian newborns confirmed the 
'muscle-thin, but adipose' or 'thin fat' phenotype of  Indian neonates. Relatively larger 
crown heel length and head compared to birth weight may suggest asymmetric 
restriction of  some tissues. 
Despite remaining smaller, Mysore children continued to deposit more adipose tissue in 
later years. The subscapular skinfold thickness of  the Mysore children was larger than 
UK and Dutch standards at 5 years of age. Head circumference was small relative to 
other body components postnatally. 
67 4.1 Data preparation 
4.1.1 Data checking and cleaning: Range checks showed that two children had 
unusually high fasting plasma glucose concentrations. This could have been because the 
children did not fast or due to errors in sampling procedures or laboratory analysis. 
These values were deemed spurious and the GTT was considered not valid (Figure 4.1). 
Figure 4.1 Mean glucose concentrations of the whole cohort and excluded values 
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4.1.2 Statistical methods: Glucose concentrations and HbA1c were normally 
distributed. The distributions of  the insulin concentrations at all time points, insulin 
resistance, and insulin increment at 30-minutes were log-normalised. T-tests were used 
to compare means between the sexes, and ODM and controls. Linear regression 
analyses were used to determine the predictors of  glucose and insulin concentrations. 
Determinants ofIGT status were tested by logistic regression. For logged variables, 
exponentiated regression co-efficients (~) were quoted to give the proportion of  change 
rather than the actual effect size. 
Diabetes mellitus was defined as a fasting glucose concentration ~  7.0, and/or 120-
minute glucose ~  11.1 mmoUl. Impaired glucose tolerance (IGT) was a fasting glucose 
concentration < 7.0 mmol/l and 120-minute glucose 2 7.8 mmol/l, but < 11.1 mmoi/l. A 
fasting glucose of~  6.1mmoUI was defined as Impaired fasting glucose (IFG). 
75 4.2.Description 
Glucose tolerance test results were available for 580 of  the 585 children who 
participated in the study. Of  these, complete data were available for 571  children. The 
number of  samples available for each analysis and the reasons for missing values are 
given in the Table 4.1. 
Table 4.1 Total number of samples available, reasons for missing data, and the 
description of glucose and insulin concentrations 
N  Median  Range  Missing  Reasons for missing 
Total  585  (IQR)  (N)  (N) 
Fasting glucose  580  4.8  2.6 to 6.5  05  Failed venepuncture (1) 
(mmol/l)  (4.6,5.1)  Refused (2) 
SEurious (2) 
30-minute glucose  573  7.3  3.6 to 12.3  12  Failed venepuncture (3) 
(mmol/l)  (6.4, 8.2)  Vomited (2) 
Refused (4) 
Child unwell  (1) 
SEurious (2) 
120-minute glucose  571  5.9  2.3 to 9.6  14  Failed venepuncture (4) 
mmol/l)  (5.3, 6.4)  Vomited (2) 
Refused (4) 
Child unwell (1) 
Others (1) 
SEurious (2) 
Fasting Insulin  580  20.5  3.2 to 193.9  05  Failed venepuncture (1) 
(pmol/l)  (13.0,30.7)  Refused (2) 
SEurious (2) 
30-minute Insulin  573  149.9  4.8 to 1025.0  12  Failed venepuncture (3) 
(pmol/l)  (90.4,229.7)  Vomited (2) 
Refused (4) 
Child unwell (1) 
SEurious (2) 
120-minute Insulin  569  85.1  8.6 to 797.9  16  Failed sample (4) 
(pmol/l)  (56.5, 127.3)  Vomited (2) 
Refused (4) 
Sick child (1) 
Others (1) 
Spurious (2) 
Insufficient samEle (2) 
HOMA  579  0.7  0.1 to 7.1  08 
(insulin resistance)  (0.5, 1.1) 
Insulin Increment  573  26.7  -10.7 to 193.2  14 
(pmollmmol)  (14.8,42.1) 
HbAlc (%)  390  5.6  4.1 to 8.4  195  Facility not available at 
(5.3,5.8)  the start of  the study 
76 4.3 Abnormal glucose tolerance 
None of  the children had diabetes. Four children (all boys) had IFG, and 22 children (12 
boys and 10 girls, P=0.5) had IGT. Seventy-five children had above normal (>6.0) 
HbAlc concentrations. 
4.3.1 Impaired Glucose Tolerance: There were no statistically significant differences 
in anthropometry between children with IGT and normal glucose tolerance (NGT) 
(Table 4.2). By definition, children with IGT had higher 120-minute glucose 
concentrations than children with NGT. They also had higher 30-minute glucose and 
l20-minute insulin concentrations. Their insulin concentrations at 30 minutes were 
lower than for the NGT children, though this was not statistically significant. HbAlc 
was similar in both groups. 
Table 4.2 Anthropometry, and glucose and insulin concentrations of children with 
and without IGT 
Measurements  IGT (22)  NGT (549)  'P' 
Weight (kg)  15.3  (2.0)  15.2  (1.9)  0.7 
CHL(cm)  105.8  (3.4)  105.6  (4.3)  0.8 
BMI(cm)  13.7  (1.2)  13.6  (1.1)  0.7 
Head (cm)  49.0  (1.0)  48.5  (1.4)  0.08 
MUAC(cm)  15.4  (1.2)  15.3  (1.2)  0.9 
Chest (cm)  49.8  (1.9)  50.1  (2.3)  0.6 
Triceps (mm)*  7.6  (6.9, 8.2)  7.7  (6.6,8.9)  0.7 
Subscapular (mm)*  6.2  (5.2,6.9)  5.9  (4.9, 7.0)  0.5 
Glucose (mmol/l) 
O-minute  4.8  (0.7)  4.8  (0.5)  0.9 
30-minute  7.9  (1.9)  7.3  (1.4)  0.04 
120-minute  8.2  (0.4)  5.8  (0.9)  <0.001 
HbA1c (%)  5.5  0.4  5.5  0.5  0.9 
Insulin (pmol/l)* 
O-minute  19.1  (8.9,36.5)  19.8  (13.0,30.4)  0.8 
30-minute  112.8  (43.9,212.7)  139.4  (91.9,230.9)  0.2 
120-minute  189.5  (124.9,254.5)  79.5  (55.2,123.8)  <0.001 
Insulin resistance*  0.7  (0.3,1.3)  0.7  (0.5,1.1)  0.8 
(HOMA) 
Insulin increment*  28.2  (9.2,37.2)  30.4  (14.8,42.4)  0.7 
(pmollmmol) 
Mean (SD), or *geometric mean (IQR) 
4.4 Age and sex on glucose and insulin concentrations 
There were no significant effects of  age on glucose and insulin concentrations. Glucose 
concentrations were similar in boys and girls, while all the insulin values were 
significantly higher in girls (Table 4.3). 
77 Table 4.4 Mean plasma glucose and insulin concentrations according to subscapular and 
triceps skinfolds, SSITR, and fat mass in quartiles 
Glucose (mmol/l)  Insulin (pmol/l)  Others 
o  mins  30 mins  120 mins  o  mins  30 mins  120 mins  Insulin  Insulin  HbAlc 
resistance  increment 
(HOMA} 
Subscapular Skinfold (mm) 
<4.9  4.8  7.0  5.7  20.7  152.1  79.3  0.74  27.6  5.6 
- 5.6  4.8  7.2  5.8  22.5  173.0  98.5  0.80  31.8  5.6 
-7.0  4.9  7.3  6.0  25.8  184.7  103.0  0.94  32.3  5.5 
>7.0  4.8  7.6  6.1  30.3  218.4  132.7  1.10  39.5  5.5 
13  0.02  0.12  0.09  1.06  1.07  1.07  1.07  1.01  -0.01 
P  0.03  <0.001  <0.001  <0.001  <0.001  <0.001  <0.001  <0.001  0.5 
Triceps Skinfold (mm) 
<6.6  4.7  7.1  5.9  21.7  153.8  91.2  0.8  27.7  5.6 
-7.7  4.8  7.2  5.9  23.9  171.2  93.9  0.9  30.6  5.5 
- 8.9  4.8  7.6  5.8  24.0  178.6  100.0  0.9  32.3  5.5 
>8.9  4.9  7.4  6.0  30.0  225.7  128.6  1.1  40.8  5.6 
13  0.02  0.08  0.04  1.05  1.08  1.05  1.05  1.02  -0.01 
P  0.02  0.004  0.07  <0.001  <0.001  0.001  <0.001  <0.001  0.7 
SSITR 
<0.67  4.8  7.3  5.8  23.9  183.9  100.9  0.8  33.5  5.6 
- 0.76  4.8  7.2  5.8  24.4  179.6  97.3  0.9  32.5  5.5 
- 0.87  4.8  7.2  6.0  23.4  183.2  102.6  0.8  33.5  5.6 
>0.87  4.8  7.4  6.0  27.6  180.7  111.5  1.0  31.6  5.5 
13  0.03  0.53  0.76  1.19  1.01  1.58  1.24  -1.04  -0.06 
P  0.8  0.1  0.003  0.3  0.97  0.01  0.3  0.5  0.7 
Fat mass (kg) 
<2.5  4.8  7.1  6.0  19.2  130.2  81.7  0.7  23.2  5.6 
-3.0  4.8  7.3  5.8  23.6  160.0  88.0  0.8  28.9  5.5 
-3.4  4.8  7.3  5.8  24.3  194.9  104.2  0.9  35.4  5.6 
>3.4  4.9  7.5  6.0  32.3  242.3  139.0  1.2  43.5  5.5 
13  0.10  0.24  0.12  1.30  1.29  1.46  1.34  1.09  -0.04 
P  0.003  0.02  0.09  <0.001  <0.001  <0.001  <0.001  <0.001  0.5 
In this and the following tables (4.5 to 4.7) sexes were combined, P values were derived using linear 
regression and all variables as continuous, adjusted for sex.  ~ values were exponentiated for insulin 
concentrations, HOMA and increment. 
4.5.3 Skeletal measurements: Height at 5 years was a strong determinant of  insulin 
concentrations (Table 4.5). This was true for both truncal (sitting height, P<O.OOl)) and 
leg lengths (P<O.005). Sitting height was also positively associated with 30-minute 
glucose concentrations (P=O.05). Larger head circumference predicted higher 30-minute 
insulin concentrations and insulin increment. No significant associations were seen with 
glucose concentrations and HbAlc. 
79 Table 4.5 Mean plasma glucose and insulin concentrations according to height and 
head circumference in quartiles 
Glucose (mmolll)  Insulin (pmolll)  Others 
o  mins  30 mins  120 mins  o  mins  30 mins  120 mins  Insulin  Insulin  HbAlc 
resistance  increment 
(HOMAl 
Height(cm) 
<102.8  4.8  7.3  5.9  22.9  162.7  85.4  0.80  29.3  5.6 
-105.5  4.8  7.1  5.8  22.8  146.7  89.0  0.81  26.3  5.5 
-108.3  4.9  7.3  6.0  25.0  192.7  114.7  0.91  34.65  5.6 
>108.3  4.8  7.4  6.0  27.4  225.3  122.4  1.0  41.1  5.5 
/3  0.01  0.01  0.01  1.03  1.03  1.03  1.03  1.01  -0.003 
P  0.2  0.4  0.3  <0.001  <0.001  <0.001  <0.001  <0.001  0.6 
Head circumference (cm) 
<47.5  4.8  7.3  5.9  25.5  178.6  95.1  0.90  32.2  5.6 
- 48.4  4.8  7.2  5.8  25.0  166.3  104.7  0.89  29.3  5.5 
- 49.5  4.9  7.4  5.9  25.7  178.9  97.3  0.93  31.7  5.5 
>49.5  4.8  7.4  6.0  23.4  205.8  115.8  0.85  38.1  5.6 
/3  0.002  0.03  0.03  -1.01  1.05  1.04  -1.01  1.01  -0.002 
P  0.9  0.5  0.3  0.7  0.04  0.07  0.8  0.05  0.9 
4.5.4 Measurements of  lean and muscle mass: Larger AMA predicted higher insulin 
concentrations at all time points, insulin resistance and insulin increment (Table 4.6). 
There was a negative association between lean residual and glucose concentration at 
120 minutes, and it was positively associated with insulin concentrations (0 and 30 
minutes), HOMA and insulin increment. No associations were seen with HbA1c levels. 
80 Table 4.8.  Multiple regression analysis of child's glucose and insulin concentrations with child's current anthropometry and parental 
characteristics (adjusted for sex). 
Glucose  (mmol/l)  Insulin  (pmoVI) *  Insulin*  Insulin *  HbAlc 
resistance  Increment 
o  mins  30 mins  120 mins  o  mins  30 mins  120 mins  (HOMA) 
Child's height (cm)  p  -0.001  -0.05  -0.03  1.005  1.002  1.01  1.01  1.003  0.002 
P  0.8  0.03  0.07  0.7  0.9  0.6  0.6  0.3  0.8 
Head circumference (cm)  p  -0.03  -0.03  0.01  -1.11  -1.05  -1.02  -1.11  -1.01  0.01 
P  0.2  0.6  0.8  <0.001  0.09  0.3  <0.001  0.04  0.6 
Fat mass (kg)  p  0.14  0.55  0.41  1.35  1.40  1.30  1.38  1.07  -0.02 
P  0.03  0.002  0.002  <0.001  0.001  0.004  <0.001  0.002  0.8 
Lean residual  p  0.01  -0.20  -0.21  -1.003  1.04  -1.06  1.002  1.01  -0.02 
P  0.9  0.02  0.001  0.9  0.4  0.1  0.97  0.2  0.6 
Maternal sum of  p  -0.003  0.0004  -0.001  1.0004  1.0001  1.0002  1.0005  1.00  0.0001 
skinfolds(mm)  P  0.6  0.8  0.4  0.6  0.9  0.8  0.5  0.9  0.8 
Paternal sum of  p  0.001  0.005  -0.001  1.002  1.003  1.002  1.002  1.001  0.001 
skinfolds(mm)  P  0.2  0.06  0.6  0.07  0.02  0.2  0.04  0.01  0.3 
Socio-economic status  p  0.002  0.03  0.01  1.005  1.01  1.003  1.01  1.001  -0.004 
P  0.6  0.05  0.5  0.5  0.2  0.7  0.4  0.5  0.5 
*Exponentiated co-efficients 
83 Table 4.9. Glucose and insulin concentrations according to maternal GDM and paternal diabetes status 
Offspring of Diabetic Mothers  pt  Control children  pt  Offspring of  Diabetic fathers 
Total  Girls  Boys  Total  Girls  Boys  Total  Girls  Boys  Total  Girls  Boys  Total  Girls  Boys 
NMax=  35  22  13  474  243  231  41  21  20 
Plasma glucose (mmol/l) 
Fasting  4.8  4.7  4.9  0.8  0.5  0.5  4.8  4.8  4.8  0.9  0.7  0.8  4.8  4.8  4.8 
(0.5)  (0.6)  (0.4)  (0.5)  (0.5)  (0.5)  (0.5)  (0.4)  (0.5) 
30-minute  7.5  7.7  7.3  0.3  0.3  0.8  7.3  7.3  7.2  0.5  0.5  0.2  7.1  7.5  6.7 
(1.4)  (1.6)  (0.9)  (1.4)  (1.4)  (1.5)  (1.3)  (1.3)  (1.6) 
120-minute  6.1  6.2  5.9  0.3  0.2  0.8  5.9  5.8  6.0  0.4  0.1  0.007  5.7  6.1  5.3 
(Ll)  (1.3)  (0.7)  (1.0)  (0.9)  (1.0)  (1.2)  (1.1)  (Ll) 
HbAlc (%)  5.6  5.7  5.4  0.6  0.5  0.5  5.5  5.5  5.6  0.4  0.5  0.6  5.6  5.6  5.6 
(0.9)  (1.0)  (0.4)  (0.5)  0.5  (0.5)  (0.4)  (0.3)  (0.5) 
IGT (N)  4  4  0.01  <0.001  0.4  15  4  11  0.1  0.01  0.97  3  2  1 
(11.4%)  (18.3%)  (0%)  (3.2%)  (1.7%)  (4.8%)  (7.7%)  (10.5%)  (5%) 
Plasma insulin (pmolll)* 
Fasting  23  25  20  0.1  0.4  0.3  19  22  17  0.2  0.7  0.1  22  23  21 
(14,35)  (17,36)  (11,32)  (12,29)  (14,32)  (11,27)  (14,34)  (18,32)  (12,36) 
30-minute  172  210  123  0.1  0.05  0.97  136  152  122  0.96  0.5  0.6  136  136  135 
(123,275)  (141,291)  (79,241)  (87,225)  (103,242)  (73,213)  (104,252)  (103,242)  (88,254) 
120-minute  105  122  82  0.03  0.04  0.7  82  90  76  0.04  0.5  0.008  63  81  49 
(73,150)  (74,171)  (52,142)  (57,127)  (62,131)  (52,121)  (29,125)  (62,131)  (25,79) 
Other insulin variables* 
Insulin  0.8  0.9  0.7  0.2  0.5  0.3  0.7  0.8  0.6  0.2  0.7  0.2  0.8  0.8  0.8 
resistance  (0.5,1.3)  (0.6,1.3)  (0.3,1.0)  (O.4,Ll)  (0.5,1.2)  (0.4,1.0)  (0.5,1.3)  (0.5,1.2)  (0.4,1.3) 
(HOMA) 
Insulin  36  44  26  0.1  0.04  0.8  29  32  27  0.7  0.8  0.4  31  30  31 
increment  (20,47)  (27,54)  (12,38)  (14,40)  (16,44)  (12,38)  (16,46)  (16,44)  (15,48) 
(pmollmmol) 
Mean (SD) or *geometric mean (IQR), tp for the difference between offspring of  diabetic mothers and controls  tp for the difference between offspring of  diabetic father and controls 
85 4.7.3 Control children: In control children, a linear increase in insulin concentrations 
at 30 minutes and insulin increment was seen with an increase in maternal glucose 
(GAUe) and insulin (lAUe) concentrations (Table 4.10). The associations with 
maternal lAUe, but not GAUe, remained statistically significant after adjusting for 
maternal and offspring skinfolds, and socio-economic status of  the family. 
When maternal fasting insulin concentrations were used as a predictor, positive 
associations with 30-minute insulin concentrations (P=0.5), HOMA (P=0.2) and insulin 
increment (P=0.2) were weak, and remained non-significant after adjusting. 
Positive associations were also observed between father's fasting insulin, and offspring 
30-minute insulin concentrations and insulin increment at 5 years (Table 4.10). These 
associations were not significant after adjusting for father's and offspring skinfolds and 
socio-economic status. 
Table 4.10 Insulin concentrations and HOMA at 5 years in the control children 
according to fourths of maternal GAUe, IAUC and paternal insulin 
Maternal GAUe  Maternal IAUe  Paternal fasting insulin 
30min  HOMA  Insulin  30min  HOMA  Insulin  30min  HOMA  Insulin 
insulin  increment  insulin  increment  insulin  increment 
1 (Lowest)  160  0.9  28  152  1.0  26  151  0.8  27 
2  182  0.9  33  161  0.9  29  176  0.9  32 
3  183  0.8  33  187  0.8  34  197  1.0  35 
4 (Highest)  196  0.9  36  224  0.9  42  201  0.9  36 
p*  0.04  0.6  0.06  <0.001  0.998  <0.001  0.04  0.02  0.01 
Pt  0.3  0.2  0.4  <0.001  0.2  <0.001  0.6  0.4  O.  3 
P *adJusted for sex t adjusted for sex, maternaV paternal sum of  skmfolds, chIld's sum of  skmfolds at 5 years, 
socio-economic status. P values were derived by multiple linear regressions, using all variables as continuous. 
4.8 Relationships to size at birth 
There were no significant linear or 'U' shaped associations between birth weight and 
glucose and insulin concentrations in the children at 5 years (Table 4.11). 
86 Table 4.11 Mean plasma glucose and insulin concentrations according to birth weight 
in quartiles 
Glucose (mmolll)  Insulin (pmolll)  Others 
Birth weight  0  30  120  0  30  120  HOMA  Insulin  HbAlc 
quartiles (kg)  mins  mins  mins  mins  mins  mins  increment 
< 2.72  4.8  7.2  5.8  25.9  187.4  103.4  0.9  33.7  5.5 
- 2.97  4.8  7.3  5.9  26.3  181.6  97.2  1.0  32.5  5.6 
- 3.24  4.8  7.3  6.0  21.8  176.6  106.9  0.8  32.9  5.5 
> 3.24  4.8  7.4  5.9  25.3  182.0  105.2  0.9  32.8  5.5 
p*  0.9  0.9  0.7  0.5  0.7  0.4  0.4  0.7  0.95 
* Adjusted for sex, birth weight used as a continuous variable. 
After excluding ODM from the analysis (the inclusion may mask inverse association 
with birth size) there were still no associations between any of  the birth measurements 
and glucose/insulin variables at 5 years. After adjusting for current weight, birth weight 
was inversely related to insulin concentrations at 30 minutes (exp(p)=-1.23, P=0.03) and 
insulin increment (exp(p)=-1.04, P= 0.05). Head circumference was inversely associated 
with fasting (exp(p)=-1.06, P=0.03) and 30-minute insulin concentrations (exp(p)= -
1.09, P=0.005), insulin increment (exp(p)=-1.06, P=0.03) and also insulin resistance 
(exp(p)=-1.02, P= 0.02). The highest values for insulin increment (Figure 4.2) and 
insulin resistance with head circumference were in children who had small heads at 
birth and were heavy at five years. Birth length was negatively associated with fasting 
glucose (p=-0.03, P= 0.005) and 30-minute insulin concentrations (exp(p)=1.03, P= 
0.02). Except birth CHL with fasting glucose, other associations became statistically 
non-significant after adjusting current subscapular skinfolds instead of  weight. 
Figure 4.2 Insulin increment according to quartiles of head circumference at birth 
and weight at five years 
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hi"h  ...  t There were no significant differences in glucose/insulin concentrations or in the 
prevalence of IGT between children who were SGA at birth compared with the rest of 
the children (Table 4.12). The HbA1c concentrations were higher in children who were 
appropriate for gestational age at birth compared with SGA children. 
Table 4.12. Glucose and insulin concentrations of SGA and AGA children 
NMax= 
Fasting glucose (mmolll) 
30-minute glucose (mmolll) 
120-minute glucose (mmolll) 
*Fasting insulin (pmolll) 
*30-minute insulin (pmolll) 
*  120-minute insulin (pmolll) 
*Insulin resistance (HOMA) 
*Insulin increment (pmollmmol) 
HbAlc 
Mean (SD) or *geometric means (IQR) 
4.9 Longitudinal growth from 0-5 years 
SGA 
57 
4.8  (0.5) 
7.3  (1.8) 
5.7  (1.0) 
19.1  (14.2,26.3) 
121.5  (64.3,243.6) 
73.0  (49.9,124.5) 
0.7  (0.5,0.9) 
28.9  (11.2,46.0) 
5.4  (0.5) 
AGA 
523 
4.8  (0.5) 
7.3  (1.4) 
5.9  (1.0) 
20.0  (12.9,31.6) 
140.2  (94.8,229.7) 
83.2  (57.8,127.7) 
0.7  (0.5,1.1) 
30.4  (15.5,42.4) 
5.6  (0.5) 
'P' 
0.7 
0.9 
0.4 
0.6 
0.2 
0.2 
0.4 
0.6 
0.06 
Longitudinal analyses were performed to determine whether growth during particular 
time periods between birth and five years was related to glucose and insulin 
concentrations. 
4.9.1 Conditional SD scores: High correlations between anthropometric measurements 
in successive years (Figure 4.3a) make it difficult to ascertain independent associations 
between change in anthropometry at any given year and glucose and insulin 
concentrations. I used conditional SD scores to measure these associations. Within 
cohort SD scores for anthropometric measurements at a given year were regressed on 
the SD scores for all previous years. The residuals obtained have the property of  being 
normally distributed. The residuals expressed as SD scores give a measure of  gain in 
size at a particular age relative to size in previous years. These values are not correlated 
with the scores for other years for a given measurement (Figure 4.3b). 
88 Fat-free mass (FFM) was obtained directly from BIA estimation. FFM was also 
calculated from skinfold equations by subtracting the fat mass from body weight. 
5.2 Statistical methods 
Fat-free mass from all methods, FM and fat% from BIA were normally distributed. Fat 
mass calculated using skinfolds from both equations (a) and (b), and fat% from (b) were 
log-normally distributed. Fat% derived from (a) had a bi-modal distribution indicating 
different distributions for boys and girls. Sex-specific SD scores were used when boys 
and girls were combined for analyses. 
5.3 Results 
Bioimpedance was measured in 584 of  585 children. A total of98 (35%) boys and 221 
(72%) girls had greater than 25% of  body weight as fat, whereas 23 (8%) boys and 92 
(30%) girls had a fat mass of  more than 30% of  body weight. 
Both FM and fat% measured by bioimpedance had higher values compared to those 
calculated using skinfolds (Table 5.1). The median values and IQR were notably 
different in all 3 methods. FM and fat% from both BIA and skinfolds were statistically 
significantly higher in girls and FFM was higher in boys. 
Table 5.1. Median (IQR) and range of  fat-free mass (FFM), fat mass (FM) and 
fat% from BIA, and skinfold equations. 
Males (N=2S0)  Females (N=305)  'P' 
Min-Max  Min-Max 
FFM(BIA)kg  11.7  8.1,22.2  10.6  7.1,15.5  <0.001 
(10.9-12.7)  (9.9-11.5) 
FM(BIA) kg  3.5  1.2,6.7  4.1  1.4,10.2  <0.001 
(2.9- 4.2)  (3.5- 4.7) 
Fat% (BIA)  22.9  8.6,35.3  27.8  11.1,43.4  <0.001 
(20.1- 26.9)  (24.4- 30.9) 
FFM(a) kg  12.6  9.4,20.4  11.4  8.5,17.3  <0.001 
(11.8-13.6)  (10.6-12.3) 
FM (a) kg*  2.5  1.6,7.1  3.3  2.2,6.8  <0.001 
(2.3- 2.9)  (3.0- 3.8) 
Fat% (a)*  16.6  13.4,25.7  22.6  20.1,29.9  <0.001 
(15.7- 17.7)  (22.0- 23.4) 
FFM (b) kg  13.3  9.8,20.4  12.8  9.2,17.8  <0.001 
(12.5-14.3)  (11.8-13.5) 
FM(b) kg*  1.9  1.0,7.1  2.0  0.9,7.5  <0.001 
(1.5- 2.3)  (1.7- 2.6) 
Fat% (b)*  12.2  7.6,26.5  13.9  7.7,32.6  <0.001 
(10.8- 14.0)  (11.9- 16.6) 
(a) derived using equation for Indian children (b) derived using Slaughter's equation * P derived using 
normalised variables for the difference between the sexes 
103 5.3.1 Offspring of diabetic mothers: 
Offspring, especially females, born to mothers with GDM had higher FFM, FM and 
fat% measured using BIA than ONDM (Table 5.2). The differences were of  borderline 
significance for FM and FFM in females. FM and fat% were smaller in male ODM than 
in male ONDM. Fat and fat-free mass, and fat% from skinfold equations were 
significantly greater in female ODM than ONDM. They were similar in boys from both 
groups. 
Table 5.2 Body fat according to maternal GDM status 
Females  Males  P* 
ODM  ONDM  ODM  ONDM  F  M 
FFM(BIA) kg  11.3  10.8  12.5  11.9  0.09  0.2 
(1.6)  (1.4)  (1.6)  (1.6) 
Fat mass (BIA) kg  4.6  4.1  3.3  3.6  0.07  0.2 
(1.3)  (Ll)  (1.0)  (0.9) 
Fat% (BIA)  28.6  27.5  20.7  23.3  0.3  0.06 
(5.6)  (5.1)  (5.9)  (4.8) 
FFM(a) kg  12.1  11.5  12.9  12.8  0.052  0.8 
(1.5)  (11.5)  (1.4)  (1.4) 
Fat mass (a)  kg~  3.7  3.4  2.6  2.6  0.01  0.8 
(3.2,4.2)  (3.0,3.7)  (2.2,3.1)  (2.3,2.9) 
Fat% (a)  23.5  22.7  16.9  16.8  0.002  0.9 
(1.2)  (1.2)  (1.7)  (1.9) 
FFM (b) kg  13.2  12.8  13.6  13.4  0.1  0.7 
(1.5)  (1.4)  (1.4)  (1.5) 
Fat mass (b)  kg~  2.5  2.1  1.9  1.9  0.006  0.8 
(2.0,3.3)  (1.6,2.5)  (1.5,2.4)  (1.6,2.3) 
Fat% (b)~  16.0  l3.9  12.4  12.5  0.006  0.9 
(l3.7,19.4)  (11.8,16.5)  (10.2,14.4)  (10.8,14.1) 
Mean (SD) or ~Igeometric mean (IQR); (a) derived using equation for Indian children (b) derived using 
Slaughter's equation *  P for the difference between ODM and ONDM, derived using normalized 
variables 
5.4 Correlations 
5.4.1 Bioimpedance and skinfold equations: FFM derived from BIA and that 
calculated from skinfold equations were strongly, positively correlated (Figure 5.2). Fat 
mass and fat% measured using BIA were also significantly correlated with those 
estimated using skinfold equations (a) and (b). The correlations were greater for FM 
than for fat% (Figure 6.2). Statistically significant correlations were also observed 
between FM from BIA, and individual skinfolds and BMI (Figure 5.3). 
104 Figure 5.2 Correlations between BIA and skinfold methods. 
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30.00 statistically significant only with BIA measurements ofFM (R=O.ll) and fat% 
(R=0.09). 
5.5 Predictors of FM and fat% 
I tested some of  the factors associated with current adiposity such as weight at birth and 
5 years, parental size, socio economic status of  the parents and maternal glucose and 
insulin status during pregnancy, using regression analyses. All these models included 
sex as an independent variable. 
5.5.1 Size at birth and current adiposity:  In a univariate analysis, birthweight 
(P<O.OOl), skeletal measurements (length and head circumference, P<O.OOl), measure 
oflean tissue (MUAC and AMA, P<O.OOl) and also skinfold measurements 
(subscapular, P=O.OOI  and triceps, P=0.03) were positively associated with FM 
measured using BIA. Ponderal index at birth was not related to FM (P=O.l). There were 
no statistically significant associations between birth size and fat%. 
5.5.2 Relationships with current anthropometry: Higher current weight and 
components of  body weight such as height, head circumference, MUAC, AMA and 
skinfolds were associated with higher FM (P<O.OOI  for all). Significant positive 
associations were also seen between fat%, and weight, MUAC, skinfold measurements 
(P<O.OOI  for all) and head circumference (P=0.02). 
5.5.3 Parental factors and bioimpedance at 5 years: Higher parental sum of  skinfolds 
(P=O.Ol  and <0.001 for mothers and fathers respectively), and socio-economic status of 
the family (P<O.OOI) were associated with offspring fat mass at 5 years. Maternal 
gestational insulin, but not glucose, concentrations were also related to higher current 
fat mass (lAUC, P<O.OOl). Only father's skinfolds and maternal IAUC were statistically 
significant predictors of  higher fat%. 
5.5.4 Multiple regression analysis: Child's birthweight, maternal IAUC and socio-
economic status (P=O.OOI  for all) were statistically significant predictors of  fat mass in 
a multivariate model. Associations with birthweight and socio-economic status were 
lost after adjusting additionally for current weight, which was then a strong determinant 
of  fat mass (P<O.OOl). Maternal IAUC remained a significant predictor even after 
adjusting for current body weight (P=0.02). Current weight (P<O.OOl) and maternal 
108 IAUC (p=O.03) were the statistically significant predictors offat% at 5 years. All the 
above associations remained little changed even after excluding the ODM from the 
analyses (Table 5.5) 
Table 5.5 Multiple regression model for predictors of fat mass and fat% using BIA 
inONDM 
Fat mass  Fat % 
p  P  P  P 
Current weight (kg)  0.33  <0.001  0.42  0.001 
Birthweight (kg)  0.01  0.9  0.43  0.5 
Maternal skinfolds  -0.001  0.5  -0.004  0.6 
Paternal skinfolds  0.002  0.1  0.01  0.1 
SES  -0.00004  0.997  -0.001  0.99 
Maternal GAUC  0.0001  0.7  -0.0004  0.8 
Maternal IAUC  0.000003  0.02  0.00002  0.03 
5.6 Summary of main fmdings 
Body fat, and fat-free mass measured using bioimpedance analyser were well correlated 
with those measured from skinfold equations. The correlation co-efficients were larger 
for FFM than for FM. However, the mean values varied widely. 
Females in general and female ODM in particular had higher fat mass and fat%. The 
FFM was greater in males. 
Female ODM had higher values for FFM, FM and fat% as measured from BIA than 
female ONDM. The differences adiposity between ODM and ONDM were greater 
when measured using skinfolds. 
Correlations between fat measurements derived from BIA and those calculated from 
skinfolds were stronger in children with higher levels of  body fat, such as in females, 
andODM. 
Correlations with risk markers were of  similar magnitude for body fat measured using 
BIA and skinfold method. 
109 In spite of  this, BIA has shown to give a reliable estimate of  fat and fat-free mass when 
compared to reference methods. Bioimpedance has been validated for use by several 
researchers, both in adults and in children, using reference methods such as DEXA, 
underwater weighing or isotope dilution methods, by developing equations suitable for 
the populations in question. Several of  these studies showed that the agreements 
between FM or FFM estimated using BIA and that of  reference methods were high (r2 
or r ;:::0.8)165-168,173. Some researchers showed that most of  the statistical variability 
noticed in FM using different equations was explained by the anthropometric variables 
in their models, while the contribution of  the impedance measure itself was minimal
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My study was not equipped to validate this relatively new method for the Indian context 
since a suitable reference method was not locally available. Total body fat was 
measured in my study children at 5 years using the bioimpedance technique, and was 
compared with the fat measures calculated using existing skinfold equations. There 
were statistically significant agreement between FFM (r >0.8), FM (r 2: 0.7) and fat% (r 
2: 0.3) from bioimpedance, and those from skinfold methods, but the actual values 
themselves differed considerably between three methods with bioimpedance measuring 
consistently higher than skinfolds. The correlations seen in my study are consistent with 
those observed between BIA measured resistance, and individual skinfolds and sum of 
skinfolds from an earlier study in children  175. The maximum correlation seen was less 
than observed in Mysore (r=0.45). The level of agreement seen in the present study is 
acceptable considering that FM and FFM measured by these 2 methods were based on 
different principles. While BIA measures TBW primarily, and then FFM, fat mass was 
derived by deducting the FFM value from body weight. On the contrary, skinfold 
equations measure body fat, and FFM was derived as a difference from body weight. In 
deriving their primary outcomes, all the equations use several constants, which may be 
different for different individuals. Nevertheless, the correlations seen for FFM were 
consistent with those seen in earlier studies comparing TBW measured using criterion 
methods and BIA. 
A few studies have also reported that BIA gave higher estimation of  body fat, similar to 
Mysore findings, compared to other methods used. One recent study in Pune, India, 
validated this method for Indian men, using deuterium dilution as the reference 
method  165. The researchers observed strong correlations between fat estimated from 
111 bioimpedance by new validated equation, and that obtained from manufacturer's 
equation on the software. However, they found that the software equation over 
estimated the fat mass by 1.2 kg in these adult men. Similarly, FM estimated using BIA 
was higher in children of Sri Lankan origin compared to FM calculated using skinfolds 
and isotope dilution, and more children were classified as obese based on this 
method
l77
• The values seen with BIA in my study may reflect that this method is 
measuring internal fat not accessible by skinfold methods, and thus giving a more 
comprehensive estimation. On the other hand, it may be a spurious finding, especially 
since the prediction equation was not calibrated for my study population, and estimation 
of  fat mass from BIA is dependent on several assumptions as noted above. 
I compared the relationships between body fat measured using BIA and skinfolds, and 
some ofthe cardio-vascular and diabetic risk factors in my study children, to assess the 
validity of  higher adiposity as given by BIA. FM and fat% measured from both BIA and 
skinfold methods were associated with the risk markers in a similar magnitude, and the 
associations were statistically significant. Thus, it is not possible to deduce any method 
as superior in my study without undertaking suitable validation of  methods using an 
accepted reference. This is one of  the future plans ofthe ongoing study, where a 
'doubly-labelled water method' will be used in a subset of  the study children to estimate 
TBW, which acts as a standard to compare TBW measured by BIA, and a suitable 
equation can be derived for the local population. 
In conclusion, BIA after appropriate calibration could be useful in estimating total body 
fat, and complementing anthropometric measurements in large field studies, especially 
since it is easy to operate and is more acceptable by subjects. However, there is a need 
for a unifying equation to suit all populations rather than having an array of  different 
equations to choose from for each community. 
112 Figure 6.2 Change in the systolic BP (with 95% CI for change) measured at 5 years 
per SD score increase in anthropometric measurements from birth to five years 
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In a similar analysis with diastolic BP (Figure 6.3), it was observed that increased gain 
in weight, height and MUAC during the first year of  life was related to higher BP at 5 
years. There were no statistically significant associations with change in size at later 
years. 
116 Figure 6.3 Change in the diastolic BP (with 95% CI for change) measured at 5 years 
per SD score increase in anthropometric measurements from birth to five years 
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6.2.4 Correlations with glucose and insulin concentrations at 5 years: There were 
positive correlations between both the systolic (R=O.18, P<O.OOl) and the diastolic BP 
(R=O.ll, P=O.007), and GAUe of  children. Positive correlations were also observed 
with HOMA (SBP R=O.1, P=O.Ol; DBP R=O.09, P=O.03), but not with lAUe or insulin 
increment.  These correlations remained statistically significant even after controlling 
for maternal GDM status. 
6.2.5 Parents' blood pressure: Maternal SBP at follow-up was positively associated 
with both systolic (B=O.13, P<O.OOl) and diastolic BP (B=O.06, P=O.02) ofthe child, 
and mother's DBP with child's diastolic BP (B=O.06, P=O.04). Similarly, statistically 
significant positive associations were seen between paternal and child's systolic 
(B=O.06, P=O.Ol) and diastolic BP (B=O.06, P=O.04), respectively. 
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5 6.3 Summary of main fmdings 
In this cohort, blood pressure tended to be higher in male offspring than in females at 5 
years. Measurements were higher in ODM than in ONDM, though the differences were 
not statistically significant. 
Current weight was the strongest predictor of  systolic BP at 5 years, even after adjusting 
for parents' BP and maternal gestational glucose/insulin concentrations. Significant 
positive associations were also observed between other components of  current body size 
such as height, MUAC and skinfold thickness, and the systolic BP. These associations 
were less strong with the diastolic BP. 
There was a non-significant inverse association between birth weight and blood 
pressure measurements after adjusting for current weight. Gain in weight and MUAC 
(surrogate oflean mass) after birth was associated with higher SBP at 5 years. Higher 
gain in size during infancy, but not other years was associated with higher DBP. 
The systolic BP at 5-year follow up in both parents was a strong positive predictor of 
systolic BP of  the offspring, independent of  other predictors. 
Higher glucose concentrations and insulin resistance in the child were associated with 
higher BP measurements. 
6.4 Discussion 
Primary elevation ofBP is a major adult disorder associated with CV disease and is one 
of  the most widely studied outcomes in relation to the 'fetal origins' hypothesis. 
Essential hypertension in children has been emerging as a public health concern in both 
developed as well as developing populations, and is particularly associated with the 
growing problem of  childhood obesity. 
Current size and BP: In my study children current size, including weight as well as 
components of  weight such as height, muscle mass (MUAC, AMA), and adiposity 
(skinfolds), was the strongest determinant of  blood pressure at this age. It is well known 
that the BP rises directly in relation to current body size, especially body mass. 
Concomitant adiposity could be an important factor leading to this association. Though, 
the mechanism for the same is not clear, the endocrine actions of  adipocytes are thought 
119 enzyme (ACE) activity in the heart, lungs and kidneys has been observed in an animal 
model, and it was proposed that alterations in ACE may be associated with altered BP 
in ODM190. However, more studies are needed in this field to understand the mechanism 
behind the hypertensive effects of  maternal hyperglycemia. 
Hypertension is known to aggregate in families. It  may be either due to genetic link or 
related to shared lifestyle by the family members. Statistically significant positive 
association between parents' and children's BP in my study conforms to these findings. 
Socio-economic status of  the family did not predict BP in our cohort. Other factors 
related to higher BP such as infant feeding and maternal smoking191  could not be 
assessed in my study as the breast-feeding was universal and none of  the mothers 
smoked. 
Children's BP was positively associated with glucose concentrations and HOMA-
resistance at five years. Several studies measuring glucose and insulin concentrations 
have shown associated BP elevation with higher glucose and insulin concentrations. 
This may suggest early clustering of  factors related to insulin resistance syndrome in 
our children. 
To conclude, my study showed a small, non-significant effect of  low birthweight and 
maternal GDM on the SBP of  children at 5 years. Blood pressure is known to rise with 
age. Even a small rise in pressure during childhood may induce smooth muscle 
hypertrophy in resistance vessels leading to further rise in BP, and a vicious cycle of 
vascular hypertrophy and higher BP192. Thus, children in the higher BP category, even 
in non-pathological levels, are more likely to become hypertensive as adults. Therefore, 
it may be essential to bring about changes in life style factors in those children who are 
at risk. 
122 7. PHYSICAL ACTIVITY MONITORING 
The role of  adiposity/obesity in the disease risk in individuals is widely recognised. The 
prenatal determinants such as genes, fetal nutrition and maternal GDM are clearly 
important in setting the adipogenic process in motion. Nevertheless, postnatal predictors 
such as dietary habits and physical activity levels are particularly critical as these can be 
modified effectively to bring about desirable changes in the risk outcome. 
Less physical exercise is associated with obesity even in children. In my study, physical 
inactivity may be an important contributor to the adiposity in children, especially in 
certain risk groups such as offspring of  diabetic mothers (ODM). Measurement of  activity 
levels may help to determine the comparative role of  physical activity in increasing the 
level of  body fat in our children. I briefly describe here some of  the methods available for 
measuring physical activity in field. 
7.1 Subjective methods 
These are the most commonly used methods in large field studies. The subjects give 
information about their activity pattern, either by answering a questionnaire, or filling-out 
detailed activity diaries for a specified period oftime (usually a week). Although this is 
the most cost-effective method, it is crude and has many disadvantages. The 
questionnaire method requires the subjects to recall their activities, and thus the 
information is often unreliable, especially in children. The activity diary gives valid 
information in most instances, but needs a high degree of  subject compliance. This 
method is difficult to use in young children. Reporting can be biased in both the methods. 
7.2 Objective methods 
These are the more reliable methods as there will be no reporting bias. Some commonly 
used techniques are: 
7.2.1 Direct observation: This method, where the activity is observed by a field worker 
over a period of  time, gives reliable information and can be used as a criterion method to 
calibrate other objective as well as subjective methods especially in children in free living 
conditions. However, it requires highly motivated field workers, and cannot be applied 
for long-term monitoring because the activity pattern may change in front ofthe observer 
and the subjects may find it intrusive. 
123 range of  counts at any single activity. Nevertheless, it was possible to categorise each 
level of  activity based on counts (Table 7.7). 
Table 7.5: Range of mean counts per minute for boys and girls - first session 
Boys 
Mean counts/minute 
Girls 
Sitting passive - watching TV  0.3 -33.6  0.4 - 3.7 
Sitting active - writing or drawing  9.2 - 467  18 - 631 
Walking slowly  937 - 1586  772 - 1197 
Walking briskly  3077 - 4256  2027 - 5338 
Climbing steps  2483 - 3764  3157 - 4099 
Running  2308 - 8582  3534 - 5209 
Free Play  2340 - 5374  1144 - 5322 
Table 7.6: Range of mean counts per minute for boys and girls - second session 
Mean counts/minute 
Boys  Girls 
Sitting passive - watching TV  0-3  0-0 
Sitting active - writing or drawing  2 - 463  0-178 
Walking slowly  592 - 2708  1292 - 2832 
Walking briskly  2240 - 5226  3135 - 5185 
Running  2738 - 8533  3986 - 4758 
Free Play  726 - 1462  470 - 1162 
Table 7.7 Cut-off counts/minute we selected to represent different intensities of 
activity compared with those calculated using existing equation 
Activity level 
Sedentary 
Light 
Moderate 
Hard 
From Mysore sessions 
<10 
10 to 400 
400 to 3000 
>3000 
132 
Based on equation194 
<706 
- 3137 
>3137 The above cut-off bands were applied to estimate time spent on light, moderate and hard 
activities for all children (Figure 7.7). 
Figure 7.7 Activity chart with cut-off bands for different levels of activity. 
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Table 7.S. Mean, range of counts (x lOs/day), and time spent on different activity 
levels (minutes/day) by all children. 
Counts/lOS (SD) 
Light activity (%) 
Moderate activity (%) 
Hard activity (%) 
Sedentary activity (%) 
Boys (N=35) 
Mean (SD) 
4.1 (1.1) 
346.2 (24.1 %) 
252.7 (17.5 %) 
19.8 (1.4 %) 
821.3 (57.0 %) 
Range 
2.4 to 7.0 
236t0519 
144 to 363 
3 to 52 
683 to 998 
Girls (N=69) 
Mean (SD) 
4.0 (1.1) 
335.7 (23.3 %) 
259.1 (18.0 %) 
17.8 (1.2 %) 
817.5 (56.8 %) 
Range 
2.2 to 7.3 
213 to 471 
126 to 399 
2 to 55 
465 to 988 
In the whole group, the average counts accumulated ranged from 2.2xl0
5 to 7.3xl0
5 
(Table 7.8). Children generally spent very little time «2%) in a day on hard intensity 
activities. There were no statistically significant differences between boys and girls for 
any of  the activity parameters. 
7.7.3 Offspring of diabetic mothers: Overall, ODM accumulated fewer counts than 
control children. This difference was clearly due to fewer counts in female ODM, while 
male ODM accumulated more counts than controls. However, none of  these associations 
were statistically significant (Table 7.9). 
133 Female ODM spent less time in light, moderate and hard activities than control girls, 
though none of  the difference reached statistical significance. In contrast, male ODM 
spent significantly more time in moderate activities (Table 7.9) 
Table 7.9 Mean counts, and minutes spent on different activity bands by ODM and 
control children 
Boys  Girls  All 
ODM  Control  ODM  Control  ODM  Control 
(9)  (9)  (22)  (22)  (31)  (31) 
Counts/lOs  4.2  3.9  3.9  4.3  4.0  4.2 
Light activity (min)  333.9  345.3  331.1  355.0  331.9  352.2 
Moderate activity (min)  277.0  225.1  256.1  266.8  262.2  254.7 
Hard activity (min)  16.9  21.0  15.3  20.8  15.8  20.9 
Sedentary activity {min}  812.2  848.7  812.9  797.3  812.7  812.2 
P for the difference <0.05 
7.7.4 Offspring of non-diabetic mothers - high fat vs.low fat children: Children who 
were in the highest quartile of subscapular skinfold thickness at 5 years spent less time in 
all activity out comes, and more in sedentary activities; statistically significant difference 
was present for light activity (Table 7.10). 
All the differences were more pronounced in females (Table 7.10). Girls in the high fat 
category also had statistically significantly lower counts than girls in the low fat group, 
and spent significantly less time in moderate activity. A similar, but weaker trend was 
present in boys. 
Table 7.10 Mean counts and time spent on different activity levels by ONDM (high 
fat and low fat categories) 
Boys  Girls  All 
High fat  Low fat  High fat  Low fat  High fat  Low fat 
(8)  (10)  (15)  (11)  (21)  (26) 
Counts/lOs  4.2  4.1  3.6  4.7  3.8  4.4 
Light activity (min)  319.1  384.2  306.4  342.4  310.8  362.3 
Moderate activity (min)  256.8  243.7  232.9  292.1  241.2  269.0 
Hard activity (min)  20.8  19.6  15.3  22.4  17.2  21.0 
Sedentary activity {min}  843.3  792.5  876.0  784.2  864.6  788.4 
P for the difference 'borderline significant, <0.05, <0.01 
134 girls to prefer sedentary activities during leisure time. However, my study did not show 
any effect of gender on physical activity as measured by Actigraphs. 
In our study, female ODM exhibited a trend of  lower counts and more sedentary activity 
than control girls, though this did not reach statistical significance. An opposite trend was 
noticed in male ODM. We had hypothesised that lower levels of  physical activity may be 
contributing to higher adiposity in our ODM, especially in females. Lack of  power may 
be a reason for the absence of  statistical significance in girls, or there may not be any 
effect of  maternal GDM on offspring physical activity. Findings in male ODM may be 
due to chance considering very few boys in our ODM group. I have not come across any 
comparable data for ODM. 
Many studies have examined the association between self-reported physical activity and 
obesity/over weight in children
203
• Studies using objective methods, especially motion 
sensors in young children are few. A study in Australia assessing physical activity using 
doubly labelled water method and a triaxial accelerometer in 5 to 10.5 year old children 
found a negative correlation between PAL, and fat% and BMI  198. Children in the highest 
tertile of  time spent in hard activities had lower percentage body fat. In another study of 
6-8 year old children in the USA, boys, but not girls who spent more time in light-
intensity activities (measured using heart rate monitors) had higher fat mass index 
(FMlheight), while PAL and EE from doubly labelled water method were positively 
associated with fat-free mass index after adjusting for sex
204
. In my study, children, 
particularly girls belonging to the higher subscapular thickness category had accumulated 
fewer counts. They also spent less time in moderate intensity activities and more in 
sedentary activities. 
In my study children, fat-free mass was positively associated with counts accumulated by 
body movements. Studies have shown that Indian adults are not only centrally adipose, 
but also have lower muscle mass than Caucasian adults of  comparable BMI  119. Low 
muscle mass (MUAC) was a feature ofIndian neonates in Pune and also in my study118. 
The above findings thus suggest two possibilities: A. children with higher lean/muscle 
mass may be more fit and thus are inclined to engage in strenuous activities than those 
with low muscularity, or B. children who are more physically active may develop higher 
lean mass than those who are more sedentary. 
138 My study showed an association between physical inactivity and body fat. The main 
objective of  our future follow-up is to attempt to achieve sustainable behavioural changes 
in physical activity in our children. Our calculations using the 'factorial method' show 
that if  a child spends 10 minutes more on hard activities instead of  sedentary activities in 
a day, the TEE increases by 200 kJ. A similar amount of  energy will be expended if  30 
minutes of  sedentary activity is converted into moderate activity. Our current pursuit is to 
understand the best means of  intervening with one activity, without bringing counter-
effective changes in the existing activity pattern (eg. Increasing hard activities by 10 
minutes may induce a child to decrease moderate activities by 30 minutes to compensate, 
thus making no changes in the energy expended as whole). Also, some of  the major 
determinants of  physical activity are related to psychosocial factors, presently, we are 
collecting information on the behavioural and social factors associated with physical 
activity in these children and their parents. A detailed scheme of  the proposed future 
study is included in the Final Discussion chapter. 
139 8. MATERNAL VITAMIN D STATUS DURING PREGNANCY 
Vitamin D is an important micronutrient regulating calcium homeostasis in the body. 
The importance of  this in maintaining skeletal growth, especially in children, is well 
known. Vitamin D is also shown to influence fetal growth, and a deficiency in the 
mother during pregnancy is associated with lower birthweight
l24
•  It has been shown in 
animals that insulin secretion is impaired in vitamin D deficiency, and restored on 
supplementation 205,206. In humans, hypovitaminosis D has been shown to be associated 
with decreased insulin sensitivity and  ~-cell function
33
• 
It has been proposed that vitamin D deficiency may contribute to the high prevalence of 
type 2 diabetes in South Asian populations
l24
. Maternal malnutrition is common in India 
and the intake of  many micronutrients is low. There is an increased demand for vitamin 
D in pregnancy and a deficiency may playa role in the onset of  gestational diabetes. 
In this chapter I examine whether in my study maternal vitamin D status is related to: 
•  Maternal GDM and insulin concentrations during pregnancy 
•  Offspring size at birth 
•  Postnatal and childhood size 
•  Glucose/insulin metabolism in the offspring at 5 years 
8.1 Clinical investigations 
Maternal vitamin D (25-hydroxyvitamin D [25(OH) D]) was measured using stored 
serum samples, selected from 573 mothers who delivered at HMH, had a term delivery 
(~37 weeks gestation) and full OGTT data. Adequate samples were available for 489 of 
these. Analysis was done at the Departments of  Diabetes and Metabolic Medicine and 
Clinical Chemistry, Royal London Hospital, by radioimmunoassay (IDS 
Immunodiagnostics Ltd, Boldon, Tyne and Wear, UK. Intra- and inter-assay variations 
were 8.8% and 10.8% respectively). Mothers were defined as vitamin D insufficient at 
vitamin D concentrations of 11-20 ng/ml and deficient at concentrations <11  ng/me
07
. 
The distribution of vitamin D concentrations was skewed and was log-transformed to 
normality. 
8.2 Calcium and vitamin D supplements 
At the time of  the study, it was routine practice by general practitioners and 
140 8.3.2 Vitamin D and neonatal size: Neonatal anthropometric measurements were 
similar in all 3 vitamin D groups (Table 8.2), even after excluding offspring born to 
mothers with gestational diabetes. In a regression model, maternal vitamin D did not 
have statistically significant associations with neonatal anthropometry after adjusting 
for baby's sex, gestational age and maternal parity. There was a statistically significant 
inverse association between vitamin D and newborn's subscapular skinfold thickness 
(exp (B)=O.999, P=O.049) after excluding ODM from analysis. 
Table 8.2. Maternal and newborn characteristics according to maternal vitamin D 
Maternal Vitamin D groups  p** 
Normal  Insufficient  Deficient 
N=154  N=176  N=159 
Mother 
Weight (kg)  55.4 (8.5)  57.3 (8.9)  56.7 (9.9)  0.2 
Height (kg)  154.0 (5.6)  155.1  (5.4)  154.6 (5.5)  0.2 
BMI (kg/m2)  23.3 (3.5)  23.9 (3.6)  23.6 (3.3)  0.4 
Sum of  skinfolds (mm)  85.8 (32.2)  90.8 (33.0)  91.6 (34.9)  0.1 
GDM (N)  10 (6.5%)  13 (7.4%)  11  (6.9%)  0.95 
*GAUC (mmol)  1135.5  1115.9  1139.1  0.9 
(1008,1248)  (980,1215)  (1015,1255) 
*IAUC (pmol)  50201.5  50307.0  52344.4  0.5 
(35111,79608)  (35167,73432)  (33225,77625) 
Baby 
Birthweight (g)  2975.4 (405)  3026.7 (391)  2988.3 (399)  0.8 
CHL (cm)  49.1  (2.5)  49.5 (2.0)  49.3 (1.8)  0.5 
CRL (cm)  32.3 (1.9)  32.5 (1.4)  32.4 (1.5)  0.5 
Leg length (cm)  16.8 (1.7)  17.0 (1.5)  16.9 (1.3)  0.9 
Ponderal Index (kg/m3)  25.1  (2.9)  25.0 (3.0)  24.9 (2.4)  0.5 
Head circumference (cm)  34.2 (1.3)  34.3 (1.2)  34.1  (1.3)  0.9 
MUAC (cm)  10.6 (0.9)  10.6 (0.9)  10.5 (0.9)  0.2 
Chest circumference (cm)  32.3 (1.7)  32.6 (1.5)  32.3 (1.5)  0.99 
Abdominal circumference (cm)  30.1(2.1)  30.6 (1.9)  30.2 (1.8)  0.9 
AMA (cm
2
)  6.8 (1.1)  6.7(1.0)  6.7 (1.1)  0.3 
*Triceps skinfold (mm)  4.3 (3.7,5.1)  4.4 (3.9,5.0)  4.2 (3.7,4.6)  0.3 
*Subscapular skinfold (mm)  4.5 (3.9,5.0)  4.7 (4.1,5.3)  4.5  (3.9,4.9~  0.9 
Means (SD) or *geometric mean (IQR); ** ANOVA, 'P' for linearity 
8.3.3 Vitamin D and postnatal anthropometry: At one year, anthropometric 
measurements ofthe infants were similar in all 3 maternal vitamin D groups (Table 8.3). 
In a univariate regression analysis there was a statistically significant positive 
association between maternal vitamin D and offspring AMA (P=O.03) after adjusting 
for sex. I used conditional z-scores at 1 year for weight, length, subscapular skinfolds, 
MUAC and AMA to examine the effects of  maternal vitamin D on the growth during 
infancy. There were no statistically significant associations between maternal vitamin D 
and growth during the first year of  life. 
142 At two years, AMA (P<O.OOl) and MUAC (P=O.003) were larger in the offspring born 
to mothers with normal vitamin D levels compared to other 2 groups (Table 8.3). 
Similarly, at 5 years, AMA was bigger in the 'normal' group (P=O.03). Regression 
analyses showed that the association between maternal 25(OH) D and offspring AMA 
were stronger at 2 years (P<O.OO 1) and remained statistically significant even at 5 years 
(P=O.O 1).  These associations remained significant even after adjusting for maternal 
BMI and socio-economic status of  the family and were unchanged after excluding ODM 
from the analysis. 
Table 8.3 Anthropometric characteristics of children according to maternal 
vitamin D groups 
Maternal Vitamin D groups  p** 
Normal  Insufficient  Deficient 
NMax=  132  151  145 
One year 
Weight (kg)  8.4 (1.2)  8.4 (1.1)  8.4 (1.1)  0.7 
CHL (cm)  73.1  (2.8)  73.2 (2.9)  73.3 (2.7)  0.7 
8MI (kg/m2)  15.7 (1.5)  15.7 (104)  15.6 (1.4)  004 
Head circumference (cm)  44.1  (104)  44.2 (1.5)  44.1  (1.4)  0.9 
MUAC (cm)  14.2 (1.2)  14.0 (1.1)  14.1  (1.1)  0.3 
Chest circumference (cm)  43.9 (2.3)  43.9 (2.2)  43.9 (2.2)  0.8 
AMA (cm2)  11.0 (1.7)  10.7 (1.6)  10.7 (1.7)  0.09 
*Triceps skinfold (mm)  7.7 (6.5,9.0)  7.6 (6.8,8.6)  7.8 (6.9,9.0)  0.4 
*Subscapular skinfold (mm)  6.4 (5.6,7.5)  6.5 (5.5,7.6)  6.4 (5.6,7.4)  0.98 
Two years 
Weight (kg)  10.6 (1.3)  10.6 (1.3)  10.5 (1.3)  0.5 
CHL (cm)  83.9 (3.2)  84.0 (304)  83.8 (3.4)  0.8 
BMI (kg/m2)  15.0 (1.1)  14.9 (1.1)  14.9 (1.1)  0.3 
Head circumference (cm)  46.4 (1.3)  46.5 (1.5)  46.3 (1.4)  0.7 
MUAC (cm)  14.9 (1.1)  14.6 (1.0)  14.5 (1.0)  0.003 
Chest circumference (cm)  46.6 (2.1)  46.2 (2.1)  46.2 (2.1)  0.2 
AMA (cm2)  12.2 (1.7)  11.8 (1.7)  11.4(1.5)  <0.001 
Triceps skinfold (mm)  7.7 (6.6,8.7)  7.7 (6.6,8.8)  7.9 (6.7,9.1)  0.5 
Subscapular skinfold (mm)  6.9 (5.8,8.1)  6.9 (5.9,8.2)  7.1  (6.0, 8.4)  004 
Five years 
Weight (kg)  15.2 (2.0)  15.4 (2.2)  15.1 (2.0)  0.5 
CHL(cm)  105.3 (4.1)  106.0 (4.5)  105.7 (4.4)  0.5 
BMI (kg/m2)  13.7 (1.2)  13.7 (1.2)  13.4 (1.0)  0.07 
Head circumference (cm)  48.5 (104)  48.5 (1.5)  48.5 (1.5)  0.8 
MUAC(cm)  15.5 (1.3)  15.3 (1.3)  15.3 (1.2)  0.1 
Chest circumference (cm)  50.0 (2.3)  50.2 (204)  50.2 (2.4)  0.5 
AMA (cm2)  13.5 (1.9)  13.1 (1.9)  13.0 (1.9)  0.03 
*Triceps skinfold (mm)  7.7 (6.6,8.7)  7.9 (6.5,9.0)  7.8 (6.7,8.9).  0.6 
*SubscaEular skinfold {mm)  6.0 (4.9,7.2)  6.2 (5.0,7.1)  5.9 (5.0,6.52  0.7 
Means (SO) or *  geometric mean (lQR); ** ANOYA, 'P' for linearity 
143 8.3.4 Glucose and insulin concentrations: The prevalence ofIGT was higher in 
children born to mothers with a vitamin D concentration <20 ng/ml than in those in the 
normal vitamin D group (5.2% v 2.3%), but the difference was not statistically 
significant. Glucose and insulin concentrations were similar in offspring in all 3 groups 
at five years (Table 8.4). HbAlc concentrations were higher in the 'low maternal 
vitamin D' groups compared to 'normal' group. 
Table 8.4 Glucose and insulin concentrations of children according to maternal 
vitamin D status during pregnancy 
Maternal Vitamin D groups  p** 
Normal  Insufficient  Deficient 
N=135  N=153  N=142 
Glucose (mmolll) 
Fasting  4.8(0.4)  4.9(0.4)  4.8 (0.6)  0.5 
30-minute  7.3 (1.3)  7.3 (1.3)  7.4 (1.5)  0.6 
120-minute  5.9 (0.9)  5.9 (1.0)  5.9 (1.0)  0.7 
HbAlc%  5.4 (0.5)  5.6 (0.5)  5.6 (0.5)  0.04 
*Insulin 
Fasting (pmolll)  20.5  20.4  18.5  0.2 
(13.3,34.9)  (13.6,30.3)  (10.9,29.6) 
30-minute (pmolll)  133.0  142.4  136.7  0.8 
(85.0,239.7)  (97.3,224.6)  (93.1,229.2) 
120-minute (pmol/l)  80.2  82.4  79.2  0.9 
(52.6,130.8)  (53.7,115.2)  (55.4,125.5) 
HOMA  0.72  0.73  0.65  0.2 
(0.5,1.2)  (0.5,1.1)  (0.4,1.1) 
Insulin increment (pmollmmo1)  29.7  30.3  30.4  0.8 
(13.9,44.3)  (16.0,39.3)  (14.6,41.4) 
IGT {N)  3 {2.3%2  8 (5.3%)  7 {5.0%2  0.3 
Means (SD) or * geometric mean (IQR); **ANOYA, 'P' for linearity 
8.4 Summary of main findings 
More than 2/3
rd of  the women in the study cohort had lower than normal vitamin D 
concentrations during pregnancy. The incidence of  GDM was similar in both the normal 
and low vitamin D groups. Vitamin D status was not associated with maternal size or 
glucose/insulin concentrations during pregnancy. 
Maternal vitamin D status was not a predictor of  neonatal size or the growth during 
infancy in the study children. Offspring AMA was positively associated with maternal 
vitamin D concentrations at 2 years and remained statistically significant at 5 years of 
age. 
144 London, glucose tolerance was reduced in vitamin deficient individuals, while 30-
minute insulin secretion was improved on supplementing with a single dose of  vitamin 
D34.  Thus, the high prevalence of  vitamin D insufficiency in south Asian populations 
may contribute to their high incidence of  type 2 diabetes124, and gestational diabetes. 
Low maternal serum vitamin D concentrations, and an increased risk of  neonatal 
hypocalcaemia have been shown in diabetic pregnancies in Spain209. In our study, the 
mother's 25(OH)D concentrations were not related to her glucose or insulin 
concentrations, or risk of gestational diabetes. Our data do not, therefore, suggest that 
vitamin D insufficiency is an important underlying cause of  gestational diabetes in this 
population. 
Low levels of  vitamin D in pregnant women lead to low vitamin D stores in the fetus
56 
and may impair fetal growth21O.  Supplementation trials of  vitamin D in Asian women 
have shown improvements in maternal and neonatal biochemical indices for calcium 
and vitamin D, and higher birthweights
55
• Our negative findings could be because 
vitamin D concentrations higher than those found in any of  our mothers are required for 
optimal fetal growth. It is also possible that our mothers lacked other nutrients required 
for vitamin D function, such as vitamin A, often deficient in pregnancy in India211. 
Activated vitamin D exerts its main effects after binding to its receptor (the VDR) and 
complexation ofthe VDR with the retinol-X receptor
212
. It is important to note that the 
criteria for insufficiency and deficiency were derived in white Caucasian populations 
and may not be appropriate for Indian women. It could be that low serum 25(OH)D 
concentrations are well compensated for by the placenta since I ,25(OH)2D is 
synthesised by the placenta
213
. 
The absence of  associations between maternal vitamin D status and neonatal 
anthropometry does not rule out other important effects on fetal and postnatal 
development. A deficiency of  neonatal vitamin D stores may retard infant growth in the 
absence of  postnatal supplementation181. In a trial involving British Asians, there was no 
difference in newborn size, but offspring of mothers supplemented with vitamin D 
during pregnancy were longer and heavier throughout infancy than the control group214. 
Though maternal vitamin D was not related to infant catch-up growth in our cohort, 
AMA was larger in the higher vitamin D group from 2 years onwards. The significance 
of  AMA is not clear. Though it is used as a proxy for muscle mass, a major part of it 
comprises bone tissue and hence the association seen with vitamin D in my study may 
146 be reflecting larger bones in these children. This may indicate long-term effects of 
maternal vitamin D on offspring growth postnatally. Alternatively, offspring of  these 
women may have similar lifestyle habits, and social environment  (diet, sun exposure) 
as their mothers, and thus have normal vitamin D levels in the body. 
Maternal vitamin D did not have any significant associations with glucose and insulin 
concentrations, and insulin resistance of children at 5 years. Since these children are 
more exposed to sunlight due to less clothing cover and longer periods of  outdoor 
activities, adequate synthesis of  vitamin D in them may have compensated for early 
insufficiency. My data demonstrates higher hbAIc concentrations in children born to 
vitamin D deficient women. Whether hbA Ic levels signal sub-clinical perturbations in 
glucose! insulin metabolism in children is not known. Long-term follow-up of  these 
children is essential to understand the effects of  maternal micronutrients on growth and 
metabolism in the offspring. 
147 Table 9.1 Characteristics of diabetic and non-diabetic GDM women during the 
index pregnancy. 
NGT  IGTIIFG  DM  P 
N=  (11)  (11)  (13) 
*GAUC (mmol)  1603.4  93.8  1620.7  186.4  2000.8  803.2  0.07 
*IAUC (pmol)  85599.5  36973.3  90435.0  26369.1  58759.5  29680.8  0.045 
*Insulin increment  33.5  1.6  50.1  1.6  27.9  2.4  0.6 
(pmollmmol) 
*HOMA  1.9  2.4  2.1  1.6  2.1  2.0  0.7 
Insulin therapy (N)  0  (0%)  3  (27.3)  4  (30.8%)  0.05 
At Follow-up 
BMI (kglm
2
)  23.6  (4.4)  26.1  (3.0)  26.7  (4.6)  0.08 
Waistlhip (ratio)  0.87  0.06  0.90  0.08  0.93  0.05  0.04 
Sum of  skinfolds mm)  88.2  (39.9)  122.8  (18.6)  116.6  (41.5)  0.08 
*HOMA  2.8  3.7  2.6  1.0  4.2  2.3  0.02 
*Insulin increment  54.0  (40.9)  43.7  (28.4)  12.0  (16.4)  0.002 
(pmollmmol) 
Mean (SD), N(%), P derived using logged variables 
Table 9.2 Characteristics of diabetic and non-diabetic GDM women at follow-up 
NGT  IGTIIFG  DM  P 
N=  (11)  (11)  (13) 
*Age (yr)  32.6  5.7  34.3  4.3  33.9  4.6  0.4 
BMI(kg/m
2
)  23.6  (4.4)  26.1  (3.0)  26.7  (4.6)  0.08 
Height (cm)  153.9  (7.9)  150.8  (6.5)  152.6  (5.0)  0.6 
Waistlhip (ratio)  0.87  0.06  0.90  0.08  0.93  0.05  0.04 
Sum of skinfolds mm)  88.2  (39.9)  122.8  (18.6)  116.6  (41.5)  0.08 
*HOMA  2.8  3.7  2.6  1.0  4.2  2.3  0.02 
*Insulin increment  54.0  (40.9)  43.7  (28.4)  12.0  (16.4)  0.002 
(pmollmmol) 
Metabolic syndrome (N)  2  (18%)  8  (73%)  11  (85%)  0.002 
Family history (N)  5  (46%)  3  (27%)  12  (92%)  0.004 
Mean (SD), N(%), P derived using logged variables 
9.2.2 Non-GDM women: The non-GDM women who had developed diabetes at 
follow-up had significantly higher glucose concentration, and lower insulin increment at 
30 minutes than NGT women during the index pregnancy (Table 9.3). 
151 At follow-up, they were older, heavier, shorter and more centrally adipose than NGT 
women, and were more insulin resistant. The prevalence of  metabolic syndrome was 
very high compared to NGT and impaired glucose groups, and they were more likely to 
have a family history of diabetes (Table 9.4). 
Table 9.3 Characteristics of diabetic and non-diabetic non-GDM women during 
the index pregnancy 
NGT  IGTIIFG  DM  P 
N=  (406)  {751  (8) 
*GAUC (mmol)  1092.0  153.1  1179.8  137.2  1119.1  175.1  <0.001 
*IAUC (pmol)  591777.4  37688.6  56614.9  28929.1  46983.8  20093.9  0.5 
*Insulin increment  70.3  2.0  49.0  2.5  53.0  1.4  <0.001 
(pmollmmol) 
*HOMA  1.1  1.8  1.3  1.9  0.95  1.8  0.5 
Mean (SD), N(%), P derived using logged variables 
Table 9.4 Characteristics of diabetic and non-diabetic non-GDM women at follow-up 
NGT  IGTIIFG  DM  P 
N=  (406)  {751  (8) 
*Age (yr)  28.4  3.8  29.6  4.3  28.8  3.2  0.03 
BMI (kg/m
2
)  23.2  (4.4)  24.8  (3.0)  28.9  4.9  <0.001 
Height (cm)  154.8  (7.9)  153.3  (6.5)  153.2  5.1  0.02 
Waist/hip (ratio)  0.88  0.07  0.92  0.07  0.95  0.09  <0.001 
Sum of  skinfolds  92.1  39.9  108.2  35.3  135.7  38.0  <0.001 
(mm) 
HOMA  1.9  1.2  2.8  1.6  5.0  1.88  0.02 
Family history of  101  (25.0%)  27  (36.0%)  5  (62.5%)  0.004 
type 2 DM(N) 
Metabolic  75  (18.2%)  44  (58.7%)  6  (75.0%)  <0.001 
s~ndrome  (N) 
Mean (SD), N(%), P derived using logged variables 
9.2.3 Predictors of diabetes at follow-up: In all the women, I examined several 
possible predictors of  diabetes using a multiple logistic regression model, including 
GDM status, GAUe and lAUe at index pregnancy, socio-economic status, age, family 
history of  diabetes and current BMI. The presence of  GDM at index pregnancy was a 
strong risk factor for diabetes (exp (B) =14.3, P=O.03) independent of  other predictors 
(Table 9.5). Similarly, higher prevalence of  diabetes in first-degree relatives and higher 
BMI at follow-up were independently associated with higher rates of  diabetes, while 
gestational lAUe was inversely associated with the prevalence of  diabetes. Maternal 
152 age and socio-economic status, and gestational GAUe did not predict diabetes at 
follow-up (Table 9.5). 
Table 9.S predictors of diabetes at follow-up in study mothers 
Predictors 
GDM (yes/no) 
GAUe (mmol) 
lAue (pmol) 
BMI (kg/m
2
) 
Family history (yes/no) 
Socio-economic status (score) 
Age (years) 
9.3 Summary of main findings 
Exp(B) 
14.3 
1.003 
0.999 
1.3 
4.9 
0.9 
0.98 
p 
0.03 
0.2 
0.03 
<0.001 
0.02 
0.09 
0.8 
The presence of  GDM during the index pregnancy greatly increased the risk of  DM in 
the study women after 5 years (37% vs. 2% in the non-GDM group). Previously GDM 
women also had higher rates oflGT/IFG and the metabolic syndrome compared to non-
GDMwomen. 
Previously gestational diabetic women who were diabetic at follow-up had lower 
gestational insulin concentrations and insulin increment than those who were normal or 
impaired glucose tolerant at follow-up for comparable insulin resistance measurements. 
None of  the GDM women who remained NGT after 5 years had received insulin 
therapy during pregnancy. 
At follow-up, the GDM women with diabetes were more centrally obese, more insulin 
resistant, and had lower insulin increment at 30-minutes than women with NGT. They 
were also considerably more insulin resistant, but had lower insulin increment when 
compared to IGT/IFG group. 
A comparison made among the three groups in the non-GDM women showed similar 
factors associated with diabetes at follow-up. 
In the whole cohort, previous diagnosis of  GDM, the presence of  family history of 
diabetes, and high current BMI predicted higher rate of  diabetes at follow-up 
independent of  other predictors. 
153 Most of  these studies report that the high gestational fasting glucose was an important 
predictor of  diabetes at follow_up217,218,221. Higher pre-pregnant weightIBMI and higher 
gain in weightIBMI post-partum were also independent risk factors commonly 
associated with later diabetes
217
,221. Family history of  diabetes was not an important risk 
factor in most studies
217
• 
Hyperglycaemia during 4-16 weeks post-partum has been shown to be an independent 
risk factor for later diabetes in GDM women
221
,224. Thus, post-partum OGTT may help 
to identify women at high risks, who need more rigorous follow-up, and may provide 
scope to modify lifestyle factors. The American Diabetes Association recommends 
evaluation of glycaemic status for all GDM women 6 weeks after delivery77. However, 
very few of  my study women returned for follow-up after delivery, a phenomenon that 
has been observed in other countries, including developed populations
224
,225. 
There has been much controversy surrounding screening for GDM, and choice of 
criteria. Countries like India, which are still struggling with health risks associated with 
poverty such as infections, are less likely to give priority to detection and management 
of  GDM and risk factors for type 2 diabetes. The absence of  consensus on diagnostic 
and management protocols across the country, lack of  specialist diabetic clinics for 
pregnant women in the majority of  the hospitals, and lack of  awareness among the 
public of  the harmful effects of  GDM are some of  the associated problems. Most of 
these issues are directly related to inadequacy of  funds, specialist personnel, and 
specialist laboratories. The hospitals that can provide facilities for the measurement of 
indices such as HbA1c are few and are not accessible to the majority of  common 
people. Educating the public about the above risks is as important as impressing upon 
the policy makers the need for better diagnostic and treatment protocols/facilities for 
gestational diabetes in public hospitals. 
155 Through these findings my study attempted to understand the origins of  high diabetic 
and cardiovascular risks among Indians. The body phenotype unique to Indian adults 
(high truncal adiposity and reduced muscularity relative to Caucasian adults) is thought 
to predispose them to high insulin resistance and associated risks later in life
l19
• A 
recent study from Pune in India, and my study demonstrated that this phenotype may be 
apparent very early in life. What determines the emergence of  this phenotype is not 
clear, though it is proposed that it may be related to fetal programming resulting from 
nutritional deficiencies or may have a genetic role
228
. The adipose neonatal phenotype 
may be of  survival advantage providing substrate for brain development, but may have 
adverse implications when coupled with unfavourable lifestyle factors. 
Though little studied, the prevalence of  diabetes in pregnant women in India may be 
rising given the high prevalence of  insulin resistance and type 2 DM among adults. 
GDM increases the risks of  future diabetes in the women themselves
217
, and is also 
associated with adiposity and type 2 DM in their offspring (Section 1.3.2). One of  the 
downsides of  the study relevant to the above findings was the insufficient information 
on maternal GDM control. The optimum GDM control is based on the prevention of 
perinatal complications in the offspring. It is not known if  the same degree of  metabolic 
control prevents long-term complications in the offspring. Earlier studies on ODM have 
observed that risks were present even though GDM control was optimum
90
-
93
. Long-
term prospective studies aimed to address these questions are difficult as it is not clear 
what should be the length of  such follow-ups. Moreover, it may be unethical to carry 
out controlled trials to determine the role of  optimum metabolic control. 
Recently, the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study was 
established to clarify many ofthese unanswered questions related to GDM and maternal 
glycaemia of  lesser degrees
229
. 
Despite limitations in the methodology, my study showed that in contrast to ODM, the 
offspring of  diabetic fathers were smaller at birth than the rest of  the cohort. This 
corresponds to studies reporting low birth weights in the offspring of  fathers with type 2 
DM, and indicates a possible genetic aetiology, where both reduced birth weight and 
insulin resistance are determined by common genes that confer risks of  future diabetes 
(The fetal insulin hypothesis, Section 1.2.4). 
159 associated with a higher risk of  developing type 2 DM. It has been shown earlier in 
obese children and adolescents in the USA that about 33% of  subjects with IGT 
developed type 2 DM on repeating GTT after 18-24 months, and this was associated 
with significant weight gain
231
. Children who became normal glucose tolerant (33%) 
had a stable weight during this period. 
Identification of  risk factors early in life provides immense scope for the primary 
prevention oftype 2 DM in India as the progress can be halted by modification of 
lifestyle factors. In adults, interventions with low-calorie diets and increased physical 
activity have been shown to promote weight loss and improved cardiovascular health 
markers
232
. The evidence for the benefits of  dietary interventions alone is not sufficient. 
In children, there is no evidence to suggest that a reduction in energy intake helps to 
reduce the risk factors. Moreover, it is not known as to what should be the amount of 
such reductions or if  it is useful in decreasing the regional adiposity in relatively 
undernourished children as in the Mysore cohort. On the other hand, restricting food 
intake may impair normal functional development of  the children such as cognitive 
development, and may have several adverse effects which may be unknown currently. 
Thus, limiting food intake in children as a means of  reducing obesity is considered 
unsuitable, and increasing physical activity may be a better approach. 
A few studies in the West have shown an association between lower levels of  physical 
activity and higher current body mass/ adiposity, and features of  insulin resistance and 
metabolic syndrome in children (Section 7.9). Though the beneficial role of  intervention 
measures to increase physical activity in decreasing body fatness is still a matter of 
controversy, it has been recommended as a means to improve long-term well being of 
the children. Activity levels are decreasing in urban Indian children consequent to 
modem lifestyle
134
• This could be a major factor contributing to increased adiposity and 
diabetes risk factors among our children. Measures to inculcate physical activity 
behaviour in them may go a long way in reducing these risks in the population as a 
whole, and this forms the main objective of  the future follow-up ofthe Mysore children. 
In my study, we observed a high prevalence of  vitamin D insufficiency in a group of 
healthy, pregnant women belonging to different socio-economic strata. Low circulating 
vitamin D is thought to contribute to the higher risk of  type 2 DM in south Asian 
adults
34
• A deficiency in the mother may also impair fetal growth
124
• In view of  the high 
prevalence of  vitamin D deficiency among pregnant women this may be a risk factor for 
162 considering the continuous association between birth weight and diabetes  45, and the 
interactions between birth weight and later growth makes the above estimate unreliable. 
However, my study did not show associations, even though it was methodologically 
superior with meticulous measurement of  birth weights with appropriate adjustments 
made for the gestational age. This implied that impaired fetal growth may have little or 
no influence on later risk in this population. 
In some studies, an absence of  associations between birth weight and outcome measures 
in children despite using standard methodology64,65 has led to the argument that the 
impact of  fetal under-nutrition is little in populations where the low birth weight is 
rare
65
, probably because almost all the fetuses are exposed to an optimum intra-uterine 
nutritional environment leading to little growth retardation. On the other hand, 
widespread fetal growth restriction among our children may have resulted in a narrow 
range of  birth weights and effect size, and may have masked associations. Moreover, 
birth weight is a crude indicator of  fetal growth retardation, and does not give a 
complete estimation of  the effects of  fetal under nutrition on different body components 
which may be better associated with risk markers, and thus may underestimate the true 
extent of  risks associated with fetal under-nutrition. 
Apparent absence of  associations may be because of  the young age of  our children. 
Systematic reviews have indicated that the strength of  association between birth weight 
and risk outcomes such as glucose and insulin concentrations or blood pressure tend to 
increase with age  75. In the UK, the size of  association between systolic BP and birth 
weight increased with increasing age of  the participants
235
• In a longitudinal study 
among British children, Whincup et al. showed that the systolic BP rose from 2.3 mm 
Hg per kg decrease in birth weight at 5-7 year of  age to about 4 mm Hg when the same 
children were examined at 9-11 years
236
. Thus, even a small effect of  birth size on a 
particular outcome such as adiposity may magnify in the presence of  an unfavourable 
postnatal environment, and accelerate/amplify the onset of  adult diseases. The 
association may become more apparent as the children get older. The adverse influence 
of  low birth size may be apparent only when coupled with accelerated postnatal growth, 
and the postnatal nutritional status and thus growth may be inadequate in my study 
children to show an association. 
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186 Figure 1 Diagram showing the scheme of blood sampling and processing 
192 Plot of  weight with subject by observer 
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195 Table IV. Intra-observer mean squared differences between sets 
Observer  Weight  Height  Head  MUAC  Hip  Waist  Biceps  Triceps  Subscapular  Supra-ileac 
A  .3750  .1675  .0788  .0863  .7500  2.2550  .7763  .8062  4.3412  7.6387 
B  .6875  .1163  .0688  .4063  1.5750  4.3900  20.1913  2.5888  20.2213  25.9687 
C  .7500  .2300  .0375  .0688  1.5950  3.3987  .5737  .5250  1.3037  4.4775 
Total  1.6042  .1713  .0617  .1871  1.3067  3.3479  7.1804  1.3067  18.6221  112.6950 
- -
197 CHECK LIST 
NO  DESCRIPTION  YES  NO  COMMENTS 
1  Consent 
2  Photograph 
3  Child's medical history 
4  Child's medical examination 
5  Mother's  questionnaire 
6  Father's questionnaire 
7  Anthropometry -child 
Anthropometry- mother 
Anthropometry- father 
8  BP- child 
BP- mother 
BP- father 
9  Bio impedance- child 
10  Blood collection - child 
Blood collection- mother 
Blood collection- father 
11  Gifts 
12  Reports - child 
Reports- mother 
Reports-father 
13  Immunization (On demand) 
14  TA 
199 CONSENT 
We  have  fully  informed  the  Parents  /  Father  /  Mother/  Guardian  of  the  child 
about the' Parthenon Study' conducted  by the MRC  unit,  HMH,  Mysore and  have covered 
all  the  points  in  the  attached  check  list.  They are  willing  to  take  part  in  the  study and  will 
undergo the tests specified. 
Check list 
1.  EMLA Cream 
2.  Glucose tolerance test for child 
3.  Fasting glucose analysis for the father, GTT for the mother 
4.  Bio-impedance for child 
5.  Blood pressure for child and parents 
6.  Complete anthropometry for child and parents 
7.  Risks / complications if any 
Interviewer's name  cOdeD 
Signature 
Date 
200 Developmental check list 
1.  Does the child define words  (5)? 
According to M.R.C. Observer  O.No  1. Yes  D 
According to mother (if different)  o.  No  1. Yes  D 
2.  Does the child name colours  (4)? 
According to M.RC  Observer  O.No  1. Yes  D 
According to mother (if different)  O.No  1. Yes  D 
3.  Can the child name the opposite for 2 words? 
According to M.RC Observer  O.  No  1. Yes  D 
According to mother (if different)  o.  No  1. Yes  D 
4.  Does the child count up to 20? 
According to M.R.C Observer  O.  No  1. Yes  D 
According to mother (if different)  o.  No  1. Yes D 
5.  Can the child tell his age? 
According to M.R.C Observer  O.  No  1. Yes  D 
According to mother (if different)  o.  No  1. Yes  D 
6.  Can the child tell his address / telephone no? 
According to M.RC Observer  o.  No  1. Yes  D 
According to mother (if different)  O.  No  1. Yes  D 
7.  Can the child copy square or a triangle? 
According to M.R.C Observer  O.No  1. Yes  D 
According to mother (if different)  O.  No  1. Yes  D 
201 8.  Can the child draw a recognizable man? 
According to M.RC Observer  O.No  1. Yes 
D 
According to mother (if different)  O.No  1. Yes  D 
9.  Does the child walk heel to toe forwards? 
According to M.RC Observer  O.  No  1. Yes 
D 
According to mother (if different)  O.  No  1. Yes 
D 
10. Does the child walk heel to toe backwards? 
According to M.RC Observer 
According to mother (if different) 
11. Can the child jump from 3 steps? 
According to MRC Observer 
According to mother (if different) 
O.  No  1. Yes  D 
O.  No  1. Yes  D 
O.  No  1. Yes D 
O.  No  1. yesD 
12. Does the child clean himself after going to toilet? 
According to mother  O.  No  1. Yes D 
13. Does the child take bath on  his own? 
According to mother  O.  No  1. yesD 
14. Can the child climb the ladder? 
According to mother  O.  No  1. yesD 
15. Does the child obey rules? 
According to mother  O.  No  1. yesD 
202 
Grade  D Health And Vaccination Status 
Has the child had any major health problems during the past one year?D 1.Yes 2.No 
If yes 
Does the child have any health problems at present? 
If yes 
Is the child taking any medications currently? 
If yes 
Has the child been vaccinated with OPT booster? 
Other vaccines given during the past year  ,-I ________  --' 
General examination: Comments and advice 
203 
cOdeD 
D  1.Yes  2.No 
cOdeD 
D  1.Yes2.No 
cOdeD 
D  1.Yes2.No 
cOdeD Blood Pressure 
Instructions: 1. Measurements to be made between 30 and 120 minutes samples. 
2.  Child should be seated quietly for 5 minutes before the measurements. 
3.  Measured only at non-cannulated side 
Time  L-I ___  ---'I  AM  Room Temperature  L-I ___  --l 
Side  D  1. Left  2.  Right 
Systolic (mm Hg)  Diastolic (mm Hg)  Pulse (beats/ 
min) 
1 
2 
Glucose Tolerance Test 
Amount of glucose given: 
Status D 1. Complete 2.  Incomplete 
Sample Time: 
Fasting  Glucose  30 mins  120 mins 
sample  finished  Sample  Sample 
(a.m.)  (a.m.)  (a.m.)  (a.m.) 
If Incomplete, Reasons L-I _________________  --l 
COdeD 
Blood Results 
Routine  GTT 
Haemoglobin  Sample  Value (mg/dl) 
Blood group  Fasting 
HbsAg status  30 minutes 
Total Count  120 minutes 
Differential Count  N:  IL:  E:  I B:  I M: 
• 
GTT Status  D  1. Abnormal  o.  Normal 
Comments 
I 
205 Mother  Date:~1  __  ~~~  __  ~~  __  ~~~ 
Name  I 
Occupation  ~I  __________________  --'1 
Status  D  1. Alive  2.  Dead 
Code  D 
Is currently pregnant?  D  1. Yes 2. No 
Obstetric History: GraVidaD  Para  D  Living  D  Dead  D  Abortions D 
Any subsequent pregnancies after the Parthenon baby? 
If yes, 
Date  GA  BW  LID fA  MfF  Hospital(name)  MOD 
f Home 
If any history of Diabetes in the pregnancy? 
If yes, age of onset 1  1  years 
Treatment given  D  1. Insulin 2. Tablets 3.  Diet 
If currently DiabetiC?D 1.Yes 2.  No 
If yes, age of onset  1 years 
Treatment given  D  1. Insulin 2. Tablets 3.  Diet 
Past and current medical problems: 
D  1. Yes 2.  No 
Pregnancy  HfO GDM. 
Complications  If yes 
Insulin 
D  1.Yes 2.  No 
Code  D 
Current drug  hr=-is::....:t=o..:...L,;rv:'---____________________________  -. 
Code  D 
206 Family history of diabetes in first degree relative 
No 
If yes  1. Yes  2.  No  Alive / Dead  Age of onset of DM 
Mother 
Father 
Sibling  1 
2 
3 
4 
Ever used tobacco regularly? 
No 
If yes 1.Used before, but now stopped 
2.  Still using 
If stopped, age of stopping 
D 
D 
D  Years 
Type I  I  D 
>---. ______  -----' Code 
Amount / Day 
Ever used alcohol regularly?  D 1. Yes 2.  No 
If yes  1. Used before now stopped D 
2. Still using  D 
If stopped, age of stopping  D 
Type of alcohol 
1--' ___  -----'I cOdeD 
Days /Week 
D 1.Yes2. 
Insulin 
D 1. Yes 2. 
Quantity / time 
D 
,  I  1. Measures/ spirit  2.  Mugs/beer  3.  Glasses/wine D 
207 Units per week L-I  ------'-_..L.-------' 
Anthropometry 
Name 
Measurer's Name ,-I _____________  ------'  Code D 
Measurements 
Weight (kg) 
Height (cm) 
Circumferences  1  2  3 
MUAC (cm) 
Head circumference (cm) 
Waist circumference (cm) 
Hip circumference (cm) 
Skinfolds 
Biceps (mm) 
Triceps (mm) 
Subscapular (mm) 
Suprailiac (mm) 
Comments: 
208 Blood Pressure 
Time  Room TemperatureL-' __  ---' 
Machine code D 1. Critikon 2.0mron 
Cuff size  D 1.Small adult 2.Medium 3.  Large adult 
Systolic (mm Hg) 
1 
2 
Blood test details 
GTT D  1. Yes  2.  No 
Blood results: 
GTT 
Diastolic (mm Hg) 
Sample  Value (mg/dl) 
Fasting 
30 minutes 
120 minutes 
Comments and advice: 
209 
Pulse (beats/ min) Father 
Date: I  I  I I 
Name  L-I ___________  ---'  Status D  1. Alive  2.  Dead 
Occupation 
If known Diabetic? D 
If yes age of onset I  I 
Treatment given  D 
Code  D 
years 
1. Insulin 2. Tablets 3.  Diet 
Past and current medical problems: 
L-__________________________  ~Codec=J 
Current drug history: 
L-__________________________  ~Codec=J 
Family history of diabetes in first degree relative  c=J 1. Yes 2. No 
If yes  Yes/No  Alive / Dead  Age of onset of OM  Insulin 
Mother 
Father 
Sibling  1 
2 
3 
4 
5 
210 Ever used tobacco regularly?  D 
If yes 1.  Used before, but now stopped D 
2.  Still using 
If stopped, age of stopping 
D 
D 
1. Yes 2. No 
Type I  I  D 
1...-. ______  -'  Code 
Amounts / Day 1 
'----------' 
Ever used alcohol regularly? D  1. Yes 2.  NO 
If yes  1. Used before now stopped D 
2.  Still using  D 
If stopped, age of stopping  D 
Type of alcohol  1'--________  ---'  cOdeD 
Days/VVeek  D 
Quantity / time  1.Measures/ spirit 2.  Mugs/beer 3.  Glasses/wine D 
Units per week 1-1  ---I._....L.----I 
211 Anth ro pometry 
Name  ~I  ____________________________________  ~ 
Measurer's Name 
cOdeD 
Measurements 
Weight (kg) 
Height (cm) 
Circumferences  1  2  3 
MUAC (cm) 
Head circumference (cm) 
Waist circumference (cm) 
Hip circumference (cm) 
Skmfolds 
Biceps (mm) 
Triceps (mm) 
Subscapular (mm) 
Suprailiac (mm) 
Comments: 
212 List the answers ego Schoolwork, Watching TV, Computer Games, Playing outside, 
Tuition Class. Then place number 1-5 beside the one which the child spends most time 
List Of  activities  Time Spent (minutes)  Number 
13. In a typical evening, how much time does the child spend on Schoolwork? 
CD Minutes  CD Hours 
14.Does the family Own a TV?  0 No 1 Yes D 
15. In a typical day, how much time does the child spend Watching TV? 
CD Minutes  CD Hours D  No TV I Not applicable 
16. Does the family own a Computer at Home?  ONo 1 Yes D 
17. Does the child visit any Cyber Cafe to use computer?  0 No 1 Yes D 
18. In a typical day, how much time does the child spend Sitting at the computer? 
CD Minutes  CD Hours D  Not applicable 
19. Does the family Own a Vehicle (Car / Two wheeler)?  0 No 1 Yes D 
20. Does the child have Space to Play near the house?  ONo 1 Yes D 
21. If  Yes, describe the space,-: _________________  _ 
(eg. Private garden, private yard, public park, public playground) 
22.  On a typical day, how much time does the child spend In Free Play Out of Doors? 
CD Minutes  CD Hours 
23. In a typical week, does your child play formal games / physical education I sports 
outside of school hours?  D 
ONo 1 Yes 
216 24. If  Yes, Which Activities? (list in order of  preference) 
Activity  Time (minutes/week) 
1 ____________________  ___ 
2 ____________________  ___ 
3---------------------
4---------------------
5-----------------------
6-----------------------
7-----------------------
8-----------------------
25. How many hours per week in total?  rn  Hours 
26. If  the project starts activities clubs for children would you be interested?  0 No 1 Yes D 
27. What time would be most convenient for you? 
a)  Weekdays:. ___________________  _ 
b)  Weekends:. ____________________  _ 
28.What activities would you choose for your child at such clubs? (list in order of 
preference) 
5 ____________________  _ 
2 ____________________  ___  6 ___________  __ 
3 ____________________  _  7 ____________________  _ 
4----------------------- 8-----------------------
29. Do you as a family, do active things together? (eg. walking, sports)  0 No 1 Yes D 
30. If  Yes, Which Activities? (list in order of  preference) 
1 ___________________  _  5 ___________________  _ 
2 ____________________  ___  6 ____________________  ___ 
3 ___________________  _  7 ___________________  _ 
217 School Meal (Describe): ----------------------------
Lunch box from home (Describe):  ----------------------
46. Does the child have Sweets or Snacks on the way to or from School?  0 No 1 Yes D 
47. Does the family eat together at Mealtimes?  ONo 1 Yes D 
48. Ifthe child is hungry in between meals, what does he/she get? (list in order of 
preference) 
1--------------------- 5---------------------
2------------------- 6---------------------
3-------------------- 7---------------------
4------------~------- 8---------------------
49. What Sweets / Snacks are routinely kept in the house? 
5---------------------
2--------------------- 6---------------------
3--------------------- 7---------------------
4--------------------- 8---------------------
50. Does your child get 'Pocket Money'?  0 No 1 Yes D 
51. What do they usually spend it on? (list in order of preference) 
5---------------------
2--------------------- 6--------------------
3--------------------- 7--------------------
4--------------------- 8--------------
220 13. Do you think that, compared with 5 years ago, formal Physical Education in school 
has 
l.  More time  2. Less time  3. About the same  4. Not known  D 
14. Compared with Mathematics or Science, how much do you think Sports or Physical 
Education classes are important for your child's future? 
1. More Important 2. Equally Important  3. Less Important  D 
15. Do you think there is a problem of Obesity among School Children Nowadays? 
ONo 1 Yes  D 
16. If  Yes, what do you suggest to overcome the problem of obesity among School 
Children? 
D 
I.Diet education 
2.Physical activity/sportslPE 
3.Combination of  diet and PE / physical activity/ sports 
4. Not known 
222 B. Centile curves derived using Mysore anthropometry 
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224 
4  5 
4  5 
97 
90 
75 
median 
25 
10 
3 
6 c. Factorial method to calculate total energy expenditure (TEE) using parental log 
1.  Basal Metabolic Rate (BMR) BMR (MJ/day) is estimated from weight and height 
using Schofield estimating equations (1985). For ages: 3-lOythe equations are: 
Males: BMR= 0.082W + 0.545H + 1.736 
Females:  BMR = 0.071 W + 0.677H + 1.553 
Where W represents weight and H represents height 
2.  Amount of  time spent on each activity was summed. Appropriate Physical Activity 
Ratio (PAR) for each activity was allocated based on the published compendium. 
The rate of  energy expenditure (EE) for each task (i.e. coded activity) was calculated 
by:BMR*PAR 
3. The total energy expenditure for each task (EEactivity) is given by:EE*time 
The individual EEactivity were summed to determine the Total Energy Expenditure 
(TEE) in KJ/day. The Physical Activity Level (PAL) is calculated by dividing the TEE 
byBMR. 
229 D. An example to show calculation of  TEE and PAL using logs, and predicted BMR 
Activity  PAR (published  BMR  EEactivity 
Child 1  code  Time (min)  compendium)  BMR(kJ/m)  (kJ/d)  EE/m (PAR*BMR)  (EE*time) 
1  15  1  2.589861111  3729.4  2.5898611  38.84792 
2  45  1.5  2.589861111  3.8847917  174.8156 
3  60  2.5  2.589861111  6.4746528  388.4792 
5  285  1.3  2.589861111  3.3668194  959.5435 
6  15  1.8  2.589861111  4.66175  69.92625 
7  75  1.8  2.589861111  4.66175  349.6313 
9  30  1.5  2.589861111  3.8847917  116.5438 
10  15  1.8  2.589861111  4.66175  69.92625 
12  15  2.5  2.589861111  6.4746528  97.11979 
13  15  1.6  2.589861111  4.1437778  62.15667 
15  15  1.8  2.589861111  4.66175  69.92625 
17  30  1  2.589861111  2.5898611  77.69583 
19  120  2.5  2.589861111  6.4746528  776.9583 
20  30  6  2.589861111  15.539167  466.175 
26  75  2  2.589861111  5.1797222  388.4792 
50,51  30  0  2.589861111  0  0 
99  15  0  2.589861111  0  0 
18  555  1  2.589861111  2.5898611  1437.373 
Total  1440 
TEE (summed 
840  EEactivity)  4106.225 
PAL {TEE/ BMR(kJ/d)}  1.101042 
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